首页 » 细胞株Cell Lines 83及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 83及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV83
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   NCI-H1498

AC   CVCL_A497

SY   H1498; H-1498

DR   Cosmic; 930485

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1512

AC   CVCL_A498

SY   H1512; H-1512

RX   PubMed=8806092;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1514

AC   CVCL_4363

SY   H1514; H-1514

DR   ATCC; CRL-5873

DR   BioSample; SAMN03152020

DR   BioSample; SAMN03472582

DR   Cosmic; 877223

DR   Cosmic; 877380

DR   Cosmic; 980949

DR   Cosmic; 1021876

DR   Cosmic; 1032419

DR   GEO; GSM794317

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20143388;

RX   PubMed=20679594;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5873; true.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; PubMed=20679594

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12 (ATCC)

ST   D13S317: 11,12 (PubMed=20679594)

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 17,21,22 (ATCC)

ST   vWA: 17,21 (PubMed=20679594)

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2641 ! NCI-BL1514

SX   Male

CA   Cancer cell line

//

ID   NCI-H1522

AC   CVCL_1474

SY   H1522; H-1522

DR   CLO; CLO_0007999

DR   ATCC; CRL-5874

DR   BioSample; SAMN03472583

DR   ChEMBL-Cells; CHEMBL3308877

DR   ChEMBL-Targets; CHEMBL2366178

DR   Cosmic; 688004

DR   Cosmic; 877224

DR   Cosmic; 877381

DR   Cosmic; 908464

DR   GDSC; 908464

DR   GEO; GSM827534

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9,11,12

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 17,20

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1548

AC   CVCL_A499

SY   H1548; H-1548

RX   PubMed=8806092;

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1563

AC   CVCL_1475

SY   H1563; H-1563

DR   CLO; CLO_0008000

DR   EFO; EFO_0002255

DR   ATCC; CRL-5875

DR   BioSample; SAMN03473021

DR   CCLE; NCIH1563_LUNG

DR   ChEMBL-Cells; CHEMBL3308457

DR   ChEMBL-Targets; CHEMBL1075514

DR   Cosmic; 753600

DR   Cosmic; 1146879

DR   Cosmic-CLP; 753600

DR   GDSC; 753600

DR   GEO; GSM434327

DR   GEO; GSM513940

DR   GEO; GSM514326

DR   GEO; GSM784195

DR   GEO; GSM794318

DR   GEO; GSM827536

DR   GEO; GSM887366

DR   GEO; GSM888444

DR   GEO; GSM1670175

DR   IGRhCellID; H1563GEO

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 9,14

ST   D16S539: 9,13

ST   D18S51: 13,17

ST   D21S11: 28,30

ST   D3S1358: 16,17

ST   D5S818: 12,13

ST   D7S820: 7,8

ST   D8S1179: 13

ST   FGA: 21,23

ST   Penta D: 12,15

ST   Penta E: 10,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1568

AC   CVCL_1476

SY   H1568; H-1568

DR   CLO; CLO_0008001

DR   EFO; EFO_0006660

DR   ATCC; CRL-5876

DR   BioSample; SAMN03471252

DR   CCLE; NCIH1568_LUNG

DR   Cosmic; 903594

DR   Cosmic; 1146880

DR   Cosmic; 1995525

DR   Cosmic-CLP; 1298348

DR   GDSC; 1298348

DR   GEO; GSM206473

DR   GEO; GSM434278

DR   GEO; GSM513941

DR   GEO; GSM514327

DR   GEO; GSM784205

DR   GEO; GSM794319

DR   GEO; GSM827505

DR   GEO; GSM887367

DR   GEO; GSM888445

DR   GEO; GSM1670176

DR   IGRhCellID; H1568GEO

DR   PRIDE; PXD002556

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 10,12

ST   D18S51: 18

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 9

ST   D7S820: 8,9

ST   D8S1179: 13,14

ST   FGA: 23

ST   Penta D: 11

ST   Penta E: 12,13

ST   TH01: 9 (ATCC; PubMed=25877200)

ST   TH01: 7,9 (Cosmic-CLP)

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H157

AC   CVCL_0463

SY   NCl-H157; H157; H-157; NCI-157

DR   BTO; BTO:0002283

DR   EFO; EFO_0003118

DR   MCCL; MCC:0000360

DR   ATCC; CRL-5802

DR   BioSample; SAMN03151855

DR   BioSample; SAMN03471738

DR   CCRID; 3111C0001CCC000113

DR   ChEMBL-Cells; CHEMBL3307706

DR   ChEMBL-Targets; CHEMBL614783

DR   Cosmic; 722053

DR   Cosmic; 724867

DR   Cosmic; 801588

DR   Cosmic; 844816

DR   Cosmic; 852006

DR   Cosmic; 876171

DR   Cosmic; 877258

DR   Cosmic; 903569

DR   Cosmic; 911847

DR   Cosmic; 917987

DR   Cosmic; 929971

DR   Cosmic; 930486

DR   Cosmic; 932921

DR   Cosmic; 934546

DR   Cosmic; 953987

DR   Cosmic; 949208

DR   Cosmic; 980960

DR   Cosmic; 1028954

DR   Cosmic; 1032432

DR   Cosmic; 1146881

DR   Cosmic; 1219061

DR   Cosmic; 1239910

DR   Cosmic; 1320185

DR   GEO; GSM6296

DR   GEO; GSM253365

DR   GEO; GSM434267

DR   GEO; GSM784238

DR   GEO; GSM794274

DR   IGRhCellID; H157GEO

DR   KCB; KCB 200814YJ

DR   KCLB; 90157

DR   PRIDE; PXD002556

RX   PubMed=1563005;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=9649128;

RX   PubMed=11005564;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=23381221;

RX   PubMed=25120651;

RX   PubMed=26361996;

WW   http://www.atcc.org/support/faqs/05d55/Cross-contamination%20of%20ATCC%20CRL-5802%20and%20ATCC%20CRL-5860-931.aspx

WW   http://www.atcc.org/support/faqs/78ebc/Contaminating%20Line%20for%20ATCC%20CRL5802%20vs%20ATCC%20CRL5860-932.aspx

WW   http://www.atcc.org/support/faqs/bb641/Misidentified%20Cell%20Lines%20ATCC%20CRL-5802%20and%20ATCC%20CRL-5860-930.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. NCI-H157 and NCI-H1264 have been shown to be identical.

CC   Omics: Deep proteome analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5802; true.

CC   Discontinued: KCLB; 90157; probable.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D5S818: 10,13

ST   D7S820: 12

ST   TH01: 7,9

ST   TPOX: 6,12

ST   vWA: 15

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3970 ! NCI-H1264

SX   Male

CA   Cancer cell line

//

ID   NCI-H1570

AC   CVCL_A500

SY   H1570; H-1570

DR   Cosmic; 722042

DR   GEO; GSM794320

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1573

AC   CVCL_1478

SY   H1573; H-1573

DR   CLO; CLO_0008002

DR   EFO; EFO_0002256

DR   ATCC; CRL-5877

DR   BioSample; SAMN03472584

DR   CCLE; NCIH1573_LUNG

DR   ChEMBL-Cells; CHEMBL3308117

DR   ChEMBL-Targets; CHEMBL1075515

DR   Cosmic; 687796

DR   Cosmic; 877243

DR   Cosmic; 877425

DR   Cosmic; 903595

DR   Cosmic; 908472

DR   Cosmic; 1995526

DR   Cosmic; 2125179

DR   Cosmic-CLP; 908472

DR   GDSC; 908472

DR   GEO; GSM794321

DR   GEO; GSM827530

DR   GEO; GSM887368

DR   GEO; GSM888446

DR   GEO; GSM1670177

DR   IGRhCellID; NCIH1573

DR   KCLB; 91573

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 12

ST   D5S818: 11,13

ST   D7S820: 9,11

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1581

AC   CVCL_1479

SY   H1581; H-1581; NCIH1581

DR   CLO; CLO_0008003

DR   EFO; EFO_0002257

DR   ATCC; CRL-5878

DR   BioSample; SAMN03472585

DR   BioSample; SAMN03472993

DR   CCLE; NCIH1581_LUNG

DR   ChEMBL-Cells; CHEMBL3308765

DR   ChEMBL-Targets; CHEMBL1075516

DR   Cosmic; 687797

DR   Cosmic; 877426

DR   Cosmic; 844597

DR   Cosmic; 980977

DR   Cosmic; 908471

DR   Cosmic; 1032449

DR   Cosmic; 1152510

DR   Cosmic; 1995527

DR   Cosmic; 2009534

DR   Cosmic-CLP; 908471

DR   GDSC; 908471

DR   GEO; GSM827484

DR   GEO; GSM844622

DR   GEO; GSM887369

DR   GEO; GSM888447

DR   GEO; GSM1670178

DR   IGRhCellID; NCIH1581

DR   KCLB; 91581

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y (ATCC)

ST   Amelogenin: X (Cosmic-CLP; PubMed=25877200)

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9

ST   D18S51: 15

ST   D21S11: 29,31

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 10,14

ST   FGA: 22

ST   Penta D: 13

ST   Penta E: 12,17

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 15,16 (ATCC; Cosmic-CLP)

ST   vWA: 16 (PubMed=25877200)

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1592

AC   CVCL_A501

SY   H1592; H-1592

RX   PubMed=8806092;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1607

AC   CVCL_A467

SY   H1607; H-1607

DR   Cosmic; 844576

DR   Cosmic; 877225

DR   Cosmic; 877382

DR   Cosmic; 1021877

DR   Cosmic; 1152485

DR   Cosmic; 1239944

DR   Cosmic; 1518103

DR   Cosmic; 2125232

DR   GEO; GSM794322

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=20679594;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 8

ST   TH01: 9.3

ST   TPOX: 8,10,11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2642 ! NCI-BL1607

SX   Male

CA   Cancer cell line

//

ID   NCI-H1608

AC   CVCL_A502

SY   H1608; H-1608

RX   PubMed=8806092;

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1618

AC   CVCL_1480

SY   H1618; H-1618

DR   CLO; CLO_0008004

DR   EFO; EFO_0002258

DR   ATCC; CRL-5879

DR   BioSample; SAMN03472586

DR   CCLE; NCIH1618_LUNG

DR   ChEMBL-Cells; CHEMBL3308314

DR   ChEMBL-Targets; CHEMBL2366290

DR   Cosmic; 753601

DR   Cosmic; 877226

DR   Cosmic; 877383

DR   Cosmic; 980950

DR   Cosmic; 1004694

DR   Cosmic; 1032420

DR   Cosmic; 1239950

DR   Cosmic; 2125233

DR   GDSC; 753601

DR   GEO; GSM380479

DR   GEO; GSM380513

DR   GEO; GSM887370

DR   GEO; GSM888448

DR   IGRhCellID; NCIH1618

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11,13

ST   D5S818: 10

ST   D7S820: 8

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1622

AC   CVCL_4364

SY   H1622; H-1622

DR   ATCC; CRL-5880

DR   BioSample; SAMN03152021

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=20143388;

WW   http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=20143388).

CC   Discontinued: ATCC; CRL-5880; true.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1623

AC   CVCL_1481

SY   H1623; H-1623

DR   CLO; CLO_0008005

DR   EFO; EFO_0002259

DR   ATCC; CRL-5881

DR   BioSample; SAMN03472994

DR   CCLE; NCIH1623_LUNG

DR   ChEMBL-Cells; CHEMBL3308766

DR   ChEMBL-Targets; CHEMBL1075517

DR   Cosmic; 687798

DR   Cosmic; 877427

DR   Cosmic; 903596

DR   Cosmic; 980978

DR   Cosmic; 1032450

DR   Cosmic; 1995528

DR   Cosmic; 2125234

DR   Cosmic-CLP; 687798

DR   GDSC; 687798

DR   GEO; GSM513942

DR   GEO; GSM514328

DR   GEO; GSM784268

DR   GEO; GSM827557

DR   GEO; GSM887371

DR   GEO; GSM888449

DR   GEO; GSM1374702

DR   GEO; GSM1670179

DR   IGRhCellID; NCIH1623

DR   KCLB; 91623

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 12

ST   D16S539: 9,12

ST   D18S51: 14

ST   D21S11: 30.2,31.2

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 13,14

ST   FGA: 20,23

ST   Penta D: 14

ST   Penta E: 7

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 15,19,20

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1628

AC   CVCL_A503

SY   H1628; H-1628

DR   ATCC; CRL-5980

DR   Cosmic; 980951

DR   Cosmic; 1032421

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Discontinued: ATCC; CRL-5980; true.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1648

AC   CVCL_1482

SY   H1648; H-1648

DR   CLO; CLO_0008006

DR   EFO; EFO_0003119

DR   ATCC; CRL-5882

DR   BioSample; SAMN03473271

DR   CCLE; NCIH1648_LUNG

DR   ChEMBL-Cells; CHEMBL3308315

DR   ChEMBL-Targets; CHEMBL2366214

DR   Cosmic; 687799

DR   Cosmic; 877244

DR   Cosmic; 877428

DR   Cosmic; 903597

DR   Cosmic; 931372

DR   Cosmic; 980979

DR   Cosmic; 1028941

DR   Cosmic; 1032451

DR   Cosmic; 1146882

DR   Cosmic; 1152511

DR   Cosmic; 1154594

DR   Cosmic; 1219083

DR   Cosmic; 1239886

DR   Cosmic; 1891893

DR   Cosmic; 1995529

DR   Cosmic; 2125235

DR   Cosmic-CLP; 687799

DR   GDSC; 687799

DR   GEO; GSM62326

DR   GEO; GSM253366

DR   GEO; GSM434268

DR   GEO; GSM794323

DR   GEO; GSM887372

DR   GEO; GSM888450

DR   GEO; GSM1670180

DR   IGRhCellID; H1648GEO

DR   LINCS; 50032

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 15

ST   D21S11: 28,30

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 23,24

ST   Penta D: 9,11

ST   Penta E: 11

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E097 ! NCI-BL1648

SX   Male

CA   Cancer cell line

//

ID   NCI-H1650

AC   CVCL_1483

SY   H1650; H-1650; H1650_CO; NCIH1650

DR   BTO; BTO:0005243

DR   CLO; CLO_0008007

DR   EFO; EFO_0002260

DR   CLDB; cl7182

DR   ATCC; CRL-5883

DR   BioSample; SAMN03472182

DR   CCLE; NCIH1650_LUNG

DR   CCRID; 3111C0001CCC000251

DR   CCRID; 3131C0001000700152

DR   ChEMBL-Cells; CHEMBL3308800

DR   ChEMBL-Targets; CHEMBL1075518

DR   Cosmic; 687800

DR   Cosmic; 877429

DR   Cosmic; 903598

DR   Cosmic; 1017829

DR   Cosmic; 1028942

DR   Cosmic; 1047096

DR   Cosmic; 1128242

DR   Cosmic; 1146883

DR   Cosmic; 1212188

DR   Cosmic; 1239904

DR   Cosmic; 1571738

DR   Cosmic; 1600606

DR   Cosmic; 1741779

DR   Cosmic; 1795296

DR   Cosmic; 1802299

DR   Cosmic; 1891894

DR   Cosmic; 1995530

DR   Cosmic; 2042866

DR   Cosmic; 2125236

DR   Cosmic-CLP; 687800

DR   GDSC; 687800

DR   GEO; GSM206474

DR   GEO; GSM253384

DR   GEO; GSM434313

DR   GEO; GSM782115

DR   GEO; GSM784207

DR   GEO; GSM794324

DR   GEO; GSM827475

DR   GEO; GSM844623

DR   GEO; GSM887373

DR   GEO; GSM888451

DR   GEO; GSM1374703

DR   GEO; GSM1670181

DR   ICLC; HTL06002

DR   IGRhCellID; H1650_COGEO

DR   IGRhCellID; NCIH1650

DR   KCLB; 91650

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22433462;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 42 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 10

ST   D21S11: 30

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 12

ST   FGA: 20,23.2 (KCLB)

ST   FGA: 20 (PubMed=25877200)

ST   Penta D: 8

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1650-Luc

AC   CVCL_4W95

DR   JCRB; JCRB1478

DR   JCRB; NIHS0723

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 8,9

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1483 ! NCI-H1650

SX   Male

CA   Cancer cell line

//

ID   NCI-H1651

AC   CVCL_1484

SY   H1651; H-1651; NCIH1651

DR   CLO; CLO_0008008

DR   EFO; EFO_0002261

DR   ATCC; CRL-5884

DR   BioSample; SAMN03472590

DR   CCLE; NCIH1651_LUNG

DR   ChEMBL-Cells; CHEMBL3308383

DR   ChEMBL-Targets; CHEMBL1075519

DR   Cosmic; 687801

DR   Cosmic; 910900

DR   Cosmic; 1609525

DR   Cosmic; 1802316

DR   Cosmic; 1995531

DR   Cosmic-CLP; 910900

DR   GDSC; 910900

DR   GEO; GSM206475

DR   GEO; GSM513975

DR   GEO; GSM514329

DR   GEO; GSM794325

DR   GEO; GSM827529

DR   GEO; GSM844624

DR   GEO; GSM887374

DR   GEO; GSM888452

DR   GEO; GSM1374704

DR   GEO; GSM1670182

DR   IGRhCellID; NCIH1651

DR   LINCS; 50033

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 17

ST   D21S11: 31.2

ST   D3S1358: 17

ST   D5S818: 12,14

ST   D7S820: 8

ST   D8S1179: 14,15

ST   FGA: 24

ST   Penta D: 13

ST   Penta E: 12,16,17

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1652

AC   CVCL_A504

SY   H1652; H-1652

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1666

AC   CVCL_1485

SY   H1666; H-1666; H1666_DA; NCIH1666

DR   CLO; CLO_0008009

DR   EFO; EFO_0002262

DR   ATCC; CRL-5885

DR   BioSample; SAMN03472948

DR   CCLE; NCIH1666_LUNG

DR   ChEMBL-Cells; CHEMBL3308118

DR   ChEMBL-Targets; CHEMBL1075520

DR   Cosmic; 684679

DR   Cosmic; 877245

DR   Cosmic; 897729

DR   Cosmic; 908473

DR   Cosmic; 914945

DR   Cosmic; 980980

DR   Cosmic; 1032452

DR   Cosmic; 1146884

DR   Cosmic; 1209729

DR   Cosmic; 1477421

DR   Cosmic; 1600604

DR   Cosmic; 1995532

DR   Cosmic; 2042869

DR   Cosmic-CLP; 908473

DR   GDSC; 908473

DR   GEO; GSM206476

DR   GEO; GSM253346

DR   GEO; GSM434303

DR   GEO; GSM794326

DR   GEO; GSM827579

DR   GEO; GSM844625

DR   GEO; GSM844626

DR   GEO; GSM844627

DR   GEO; GSM887375

DR   GEO; GSM888453

DR   GEO; GSM1374705

DR   GEO; GSM1670183

DR   IGRhCellID; H1666_DAGEO

DR   IGRhCellID; NCIH1666

DR   KCLB; 25885

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 15

ST   D16S539: 13

ST   D18S51: 14

ST   D21S11: 29,32.2

ST   D3S1358: 16,18

ST   D5S818: 10

ST   D7S820: 8,11

ST   D8S1179: 13,14

ST   FGA: 20.2,21

ST   Penta D: 10

ST   Penta E: 14

ST   TH01: 8,9.3

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1670

AC   CVCL_A505

SY   H1670; H-1670

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1672

AC   CVCL_1486

SY   H1672; H-1672

DR   BTO; BTO:0005975

DR   CLO; CLO_0008010

DR   ATCC; CRL-5886

DR   BioSample; SAMN03473009

DR   Cosmic; 688005

DR   Cosmic; 852002

DR   Cosmic; 877227

DR   Cosmic; 980952

DR   Cosmic; 1021878

DR   Cosmic; 1032422

DR   Cosmic; 1759264

DR   Cosmic; 1891912

DR   Cosmic; 2125237

DR   GEO; GSM794327

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 13,14

ST   D21S11: 29,32.2

ST   D3S1358: 18

ST   D5S818: 11,13

ST   D7S820: 10

ST   D8S1179: 11,14

ST   FGA: 21

ST   Penta D: 8,12

ST   Penta E: 9

ST   TH01: 10

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2643 ! NCI-BL1672

SX   Male

CA   Cancer cell line

//

ID   NCI-H1684

AC   CVCL_3972

SY   H1684; H-1684

DR   BTO; BTO:0003243

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1688

AC   CVCL_1487

SY   H1688; H-1688; NCIH1688

DR   BTO; BTO:0005966

DR   CLO; CLO_0008011

DR   ATCC; CCL-257

DR   BCRC; 60497

DR   BioSample; SAMN03471387

DR   CCRID; 3131C0001000700154

DR   Cosmic; 1995533

DR   Cosmic-CLP; 1298349

DR   GDSC; 1298349

DR   GEO; GSM784264

DR   GEO; GSM986174

DR   GEO; GSM1670184

DR   KCLB; 91688

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 13

ST   D5S818: 10

ST   D7S820: 12

ST   TH01: 6,8

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E098 ! NCI-BL1688

SX   Male

CA   Cancer cell line

//

ID   NCI-H1693

AC   CVCL_1488

SY   H1693; H-1693

DR   CLO; CLO_0008012

DR   EFO; EFO_0006661

DR   ATCC; CRL-5887

DR   BioSample; SAMN03472587

DR   CCLE; NCIH1693_LUNG

DR   ChEMBL-Cells; CHEMBL3308458

DR   ChEMBL-Targets; CHEMBL1075521

DR   Cosmic; 687802

DR   Cosmic; 877430

DR   Cosmic; 903599

DR   Cosmic; 980981

DR   Cosmic; 1032453

DR   Cosmic; 1995534

DR   Cosmic-CLP; 687802

DR   GDSC; 687802

DR   GEO; GSM513943

DR   GEO; GSM514330

DR   GEO; GSM784269

DR   GEO; GSM794328

DR   GEO; GSM827560

DR   GEO; GSM887376

DR   GEO; GSM888454

DR   GEO; GSM1670185

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 11

ST   D16S539: 10

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1694

AC   CVCL_1489

SY   H1694; H-1694

DR   CLO; CLO_0008013

DR   EFO; EFO_0002263

DR   ATCC; CRL-5888

DR   BioSample; SAMN03473010

DR   CCLE; NCIH1694_LUNG

DR   ChEMBL-Cells; CHEMBL3308555

DR   ChEMBL-Targets; CHEMBL2366333

DR   Cosmic; 688006

DR   Cosmic; 1995535

DR   Cosmic-CLP; 688006

DR   GDSC; 688006

DR   GEO; GSM887377

DR   GEO; GSM888455

DR   GEO; GSM1670186

DR   GEO; GSM1682806

DR   IGRhCellID; NCIH1694

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 15,17

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 12,13

ST   FGA: 25

ST   Penta D: 13

ST   Penta E: 11,12

ST   TH01: 6,9

ST   TPOX: 11

ST   vWA: 15,16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1703

AC   CVCL_1490

SY   H1703; H-1703; NCIH1703

DR   BTO; BTO:0003009

DR   CLO; CLO_0008014

DR   EFO; EFO_0002264

DR   ATCC; CRL-5889

DR   BioSample; SAMN03472937

DR   CCLE; NCIH1703_LUNG

DR   CCRID; 3111C0001CCC000353

DR   ChEMBL-Cells; CHEMBL3308503

DR   ChEMBL-Targets; CHEMBL1075522

DR   Cosmic; 687803

DR   Cosmic; 903600

DR   Cosmic; 908474

DR   Cosmic; 980982

DR   Cosmic; 1017827

DR   Cosmic; 1028952

DR   Cosmic; 1032454

DR   Cosmic; 1202065

DR   Cosmic; 1219064

DR   Cosmic; 1239887

DR   Cosmic; 1870265

DR   Cosmic; 1995536

DR   Cosmic; 2009535

DR   Cosmic; 2042871

DR   Cosmic; 2125180

DR   Cosmic-CLP; 908474

DR   GDSC; 908474

DR   GEO; GSM206477

DR   GEO; GSM434786

DR   GEO; GSM784217

DR   GEO; GSM794329

DR   GEO; GSM827485

DR   GEO; GSM844628

DR   GEO; GSM887378

DR   GEO; GSM888456

DR   GEO; GSM1374706

DR   GEO; GSM1374707

DR   GEO; GSM1670187

DR   IGRhCellID; NCIH1703

DR   KCLB; 91703

DR   LINCS; 50034

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24805778;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=4676

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 10,12

ST   D18S51: 17,18

ST   D21S11: 29

ST   D3S1358: 16,17

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 11,13

ST   FGA: 20

ST   Penta D: 10

ST   Penta E: 10,12

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1710

AC   CVCL_A506

SY   H1710; H-1710

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1717

AC   CVCL_A507

SY   H1717; H-1717

DR   ATCC; CRL-5890

DR   BioSample; SAMN03472588

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Discontinued: ATCC; CRL-5890; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 13

ST   D7S820: 8,9

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1725

AC   CVCL_A508

SY   H1725; H-1725

DR   Cosmic; 722051

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1726

AC   CVCL_A476

SY   H1726; H-1726

DR   Cosmic; 877431

DR   Cosmic; 1152512

RX   PubMed=8806092;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H1734

AC   CVCL_1491

SY   H1734; H-1734

DR   CLO; CLO_0008015

DR   EFO; EFO_0006662

DR   ATCC; CRL-5891

DR   BioSample; SAMN03471721

DR   CCLE; NCIH1734_LUNG

DR   ChEMBL-Cells; CHEMBL3308767

DR   ChEMBL-Targets; CHEMBL1075523

DR   Cosmic; 722058

DR   Cosmic; 1146885

DR   Cosmic; 1609515

DR   Cosmic; 1995537

DR   Cosmic-CLP; 722058

DR   GDSC; 722058

DR   GEO; GSM434328

DR   GEO; GSM513944

DR   GEO; GSM514331

DR   GEO; GSM794330

DR   GEO; GSM827507

DR   GEO; GSM887379

DR   GEO; GSM888457

DR   GEO; GSM1374708

DR   GEO; GSM1670188

DR   IGRhCellID; H1734GEO

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 13,15

ST   D21S11: 33.2

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 11

ST   Penta E: 12,14

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1755

AC   CVCL_1492

SY   H1755; H-1755; NCIH1755

DR   CLO; CLO_0008016

DR   ATCC; CRL-5892

DR   BioSample; SAMN03472589

DR   CCLE; NCIH1755_LUNG

DR   ChEMBL-Cells; CHEMBL3308768

DR   ChEMBL-Targets; CHEMBL1075524

DR   Cosmic; 684677

DR   Cosmic; 684678

DR   Cosmic; 903601

DR   Cosmic; 908475

DR   Cosmic; 980983

DR   Cosmic; 1032455

DR   Cosmic; 1146886

DR   Cosmic; 1209732

DR   Cosmic; 1477423

DR   Cosmic; 1995538

DR   Cosmic; 2472918

DR   Cosmic-CLP; 908475

DR   GDSC; 908475

DR   GEO; GSM434279

DR   GEO; GSM513945

DR   GEO; GSM514332

DR   GEO; GSM794331

DR   GEO; GSM827558

DR   GEO; GSM887380

DR   GEO; GSM888458

DR   GEO; GSM1374709

DR   GEO; GSM1670189

DR   IGRhCellID; NCIH1755

DR   KCLB; 91755

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=24805778;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): ATCC; Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 12

ST   FGA: 20,25

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1755A

AC   CVCL_L169

SY   H1755A; H-1755A

DR   KCLB; 91755A

CC   Derived from metastatic site: Liver.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1492 ! NCI-H1755

SX   Female

CA   Cancer cell line

//

ID   NCI-H1769

AC   CVCL_A509

SY   H1769; H-1769

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1770

AC   CVCL_1493

SY   H1770; H-1770; NCIH1770

DR   CLO; CLO_0008017

DR   EFO; EFO_0002265

DR   ATCC; CRL-5893

DR   BioSample; SAMN03473294

DR   ChEMBL-Cells; CHEMBL3308316

DR   ChEMBL-Targets; CHEMBL2366171

DR   Cosmic; 687804

DR   Cosmic; 877269

DR   Cosmic; 980984

DR   Cosmic; 1004695

DR   Cosmic; 1032456

DR   Cosmic; 1146887

DR   Cosmic; 1239953

DR   Cosmic; 1802298

DR   Cosmic; 1891895

DR   Cosmic; 1995539

DR   Cosmic; 2125213

DR   Cosmic-CLP; 687804

DR   GDSC; 687804

DR   GEO; GSM434304

DR   GEO; GSM844629

DR   GEO; GSM1670190

DR   IGRhCellID; NCIH1770

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11314036;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H1770.html

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 13

ST   D16S539: 12,13

ST   D18S51: 14,16

ST   D21S11: 30,32.2

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9,10

ST   Penta E: 7,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 18,19

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2644 ! NCI-BL1770

SX   Male

CA   Cancer cell line

//

ID   NCI-H1781

AC   CVCL_1494

SY   H1781; H-1781; NCIH1781

DR   CLO; CLO_0008018

DR   EFO; EFO_0006663

DR   ATCC; CRL-5894

DR   BioSample; SAMN03471698

DR   CCLE; NCIH1781_LUNG

DR   Cosmic; 877432

DR   Cosmic; 897517

DR   Cosmic; 897728

DR   Cosmic; 903568

DR   Cosmic; 914946

DR   Cosmic; 980985

DR   Cosmic; 1032457

DR   Cosmic; 1128243

DR   Cosmic; 1146888

DR   Cosmic; 1802296

DR   Cosmic; 1995540

DR   Cosmic-CLP; 1298350

DR   GDSC; 1298350

DR   GEO; GSM206478

DR   GEO; GSM253348

DR   GEO; GSM434280

DR   GEO; GSM794333

DR   GEO; GSM827359

DR   GEO; GSM887381

DR   GEO; GSM888459

DR   GEO; GSM1374710

DR   GEO; GSM1670191

DR   IGRhCellID; H1781GEO

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'NSI-H1781' in Cosmic 897517.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 14

ST   D16S539: 8

ST   D18S51: 14

ST   D21S11: 28,31

ST   D3S1358: 15

ST   D5S818: 10

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 22,23

ST   Penta D: 11,13

ST   Penta E: 17

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 14

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1788

AC   CVCL_A510

SY   H1788; H-1788

DR   ATCC; CRL-5981

DR   Cosmic; 1891913

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Discontinued: ATCC; CRL-5981; true.

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1792

AC   CVCL_1495

SY   H1792; H-1792; NCIH1792

DR   BTO; BTO:0005836

DR   CLO; CLO_0008019

DR   EFO; EFO_0002266

DR   ATCC; CRL-5895

DR   BioSample; SAMN03470834

DR   CCLE; NCIH1792_LUNG

DR   ChEMBL-Cells; CHEMBL3308816

DR   ChEMBL-Targets; CHEMBL1075525

DR   Cosmic; 722044

DR   Cosmic; 724868

DR   Cosmic; 877246

DR   Cosmic; 877433

DR   Cosmic; 903603

DR   Cosmic; 980986

DR   Cosmic; 1032458

DR   Cosmic; 1146889

DR   Cosmic; 1152513

DR   Cosmic; 1891896

DR   Cosmic; 1995541

DR   Cosmic-CLP; 724868

DR   GDSC; 724868

DR   GEO; GSM253305

DR   GEO; GSM434329

DR   GEO; GSM784206

DR   GEO; GSM784257

DR   GEO; GSM794334

DR   GEO; GSM827476

DR   GEO; GSM887382

DR   GEO; GSM888460

DR   GEO; GSM1670192

DR   IGRhCellID; NCIH1792

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 45 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 10,11

ST   D18S51: 15,17

ST   D21S11: 31

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 12,15

ST   FGA: 22,24

ST   Penta D: 13

ST   Penta E: 8,10

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 14,16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1793

AC   CVCL_1496

SY   H1793; H-1793

DR   CLO; CLO_0008020

DR   EFO; EFO_0002267

DR   ATCC; CRL-5896

DR   BioSample; SAMN03472601

DR   CCLE; NCIH1793_LUNG

DR   ChEMBL-Cells; CHEMBL3308579

DR   ChEMBL-Targets; CHEMBL1075526

DR   Cosmic; 687806

DR   Cosmic; 903604

DR   Cosmic; 908463

DR   Cosmic; 1609519

DR   Cosmic; 1995542

DR   Cosmic-CLP; 908463

DR   GDSC; 908463

DR   GEO; GSM206479

DR   GEO; GSM513946

DR   GEO; GSM514333

DR   GEO; GSM784270

DR   GEO; GSM794335

DR   GEO; GSM827508

DR   GEO; GSM887383

DR   GEO; GSM888461

DR   GEO; GSM1374711

DR   GEO; GSM1670193

DR   IGRhCellID; NCIH1793

DR   KCLB; 91793

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 8,12

ST   D16S539: 13

ST   D18S51: 10,18

ST   D21S11: 28

ST   D3S1358: 17,18

ST   D5S818: 11,12

ST   D7S820: 7,8

ST   D8S1179: 8,13

ST   FGA: 23,24 (KCLB)

ST   FGA: 23.2,24 (PubMed=25877200)

ST   Penta D: 13,14

ST   Penta E: 14,16

ST   TH01: 9,9.3 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   TH01: 9 (KCLB)

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1819

AC   CVCL_1497

SY   H1819; H-1819

DR   CLO; CLO_0008021

DR   ATCC; CRL-5897

DR   Cosmic; 877247

DR   Cosmic; 877434

DR   Cosmic; 903605

DR   Cosmic; 1146890

DR   Cosmic; 1152514

DR   Cosmic; 1219065

DR   Cosmic; 1239888

DR   Cosmic; 2125181

DR   GEO; GSM62327

DR   GEO; GSM253312

DR   GEO; GSM434252

DR   GEO; GSM794336

DR   IGRhCellID; H1819_02%20GEO

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; PubMed=11416159; PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 11

ST   D16S539: 10

ST   D18S51: 15

ST   D21S11: 29

ST   D5S818: 10,12

ST   D7S820: 9,10

ST   D8S1179: 12,15

ST   FGA: 22

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E099 ! NCI-BL1819

SX   Female

CA   Cancer cell line

//

ID   NCI-H182

AC   CVCL_A511

SY   H182; H-182

DR   Cosmic; 844548

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1824

AC   CVCL_A512

SY   H1824; H-1824

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E100 ! NCI-BL1824

SX   Male

CA   Cancer cell line

//

ID   NCI-H1836

AC   CVCL_1498

SY   H1836; H-1836

DR   CLO; CLO_0008022

DR   ATCC; CRL-5898

DR   BioSample; SAMN03472591

DR   CCLE; NCIH1836_LUNG

DR   Cosmic; 980953

DR   Cosmic; 1032423

DR   Cosmic; 1759267

DR   Cosmic-CLP; 1240182

DR   GDSC; 1240182

DR   GEO; GSM887384

DR   GEO; GSM888462

DR   GEO; GSM986175

DR   GEO; GSM1670194

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12

ST   D16S539: 11,13

ST   D5S818: 11

ST   D7S820: 11,12

ST   TH01: 8,9.3

ST   TPOX: 9,10

ST   vWA: 16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1838

AC   CVCL_1499

SY   H1838; H-1838; NCIH1838

DR   BTO; BTO:0005779

DR   CLO; CLO_0008023

DR   EFO; EFO_0002268

DR   ATCC; CRL-5899

DR   BioSample; SAMN03471784

DR   CCLE; NCIH1838_LUNG

DR   ChEMBL-Cells; CHEMBL3308317

DR   ChEMBL-Targets; CHEMBL2366346

DR   Cosmic; 687807

DR   Cosmic; 877435

DR   Cosmic; 980987

DR   Cosmic; 1032459

DR   Cosmic; 1146891

DR   Cosmic; 1152515

DR   Cosmic; 1995543

DR   Cosmic-CLP; 687807

DR   GDSC; 687807

DR   GEO; GSM206480

DR   GEO; GSM434330

DR   GEO; GSM513949

DR   GEO; GSM514334

DR   GEO; GSM784224

DR   GEO; GSM794337

DR   GEO; GSM887385

DR   GEO; GSM888463

DR   GEO; GSM1374712

DR   GEO; GSM1374713

DR   GEO; GSM1670195

DR   IGRhCellID; NCIH1838

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 13

ST   D18S51: 17

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 8

ST   D8S1179: 14

ST   FGA: 20,23.2

ST   Penta D: 9,13

ST   Penta E: 12

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1869

AC   CVCL_1500

SY   H1869; H-1869; NCIH1869

DR   CLO; CLO_0008024

DR   EFO; EFO_0006664

DR   ATCC; CRL-5900

DR   BioSample; SAMN03472995

DR   CCLE; NCIH1869_LUNG

DR   Cosmic; 1995544

DR   Cosmic-CLP; 1240183

DR   GDSC; 1240183

DR   GEO; GSM434787

DR   GEO; GSM794338

DR   GEO; GSM844630

DR   GEO; GSM844631

DR   GEO; GSM887386

DR   GEO; GSM888464

DR   GEO; GSM1374714

DR   GEO; GSM1374715

DR   GEO; GSM1670196

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 12,18

ST   D21S11: 31

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 13,14

ST   FGA: 22

ST   Penta D: 11

ST   Penta E: 7,10

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H187

AC   CVCL_1501

SY   H187; H-187; NCIH187

DR   BTO; BTO:0003021

DR   CLO; CLO_0008025

DR   EFO; EFO_0002269

DR   ATCC; CRL-5804

DR   BioSample; SAMN03471879

DR   ChEMBL-Cells; CHEMBL3308878

DR   ChEMBL-Targets; CHEMBL2366276

DR   Cosmic; 688007

DR   Cosmic; 844549

DR   Cosmic; 850441

DR   Cosmic; 877201

DR   Cosmic; 877353

DR   Cosmic; 1006524

DR   Cosmic; 1021854

DR   Cosmic; 1152463

DR   Cosmic; 1219099

DR   Cosmic; 1998283

DR   Cosmic; 2125193

DR   Cosmic-CLP; 688007

DR   GDSC; 688007

DR   GEO; GSM169435

DR   GEO; GSM380510

DR   GEO; GSM380514

DR   GEO; GSM482516

DR   GEO; GSM536329

DR   GEO; GSM784232

DR   GEO; GSM794275

DR   GEO; GSM844632

DR   GEO; GSM845554

DR   GEO; GSM986173

DR   GEO; GSM1670197

DR   IGRhCellID; NCIH187

DR   KCLB; 90187

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-291.html

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'NCIN187' in GEO GSM845554.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 16

ST   D21S11: 28,29

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 25

ST   Penta D: 8,16

ST   Penta E: 12,15

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1870

AC   CVCL_1502

SY   H1870; H-1870

DR   CLO; CLO_0008026

DR   ATCC; CRL-5901

DR   BioSample; SAMN03151856

DR   BioSample; SAMN03472592

DR   Cosmic; 1021879

DR   GEO; GSM168280

RX   PubMed=8806092;

RX   PubMed=8806103;

WW   http://www.atcc.org/support/faqs/d2b8d/NCIH1304%20ATCC%20CRL5862-1069.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. NCI-H1304 and NCI-H1870 have been shown to be identical.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5901; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 14

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9,12

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1462 ! NCI-H1304

SX   Female

CA   Cancer cell line

//

ID   NCI-H1876

AC   CVCL_1503

SY   H1876; H-1876

DR   CLO; CLO_0008027

DR   ATCC; CRL-5902

DR   CCLE; NCIH1876_LUNG

DR   Cosmic; 877384

DR   Cosmic; 1032424

DR   Cosmic; 1152486

DR   Cosmic; 1891914

DR   Cosmic-CLP; 1330972

DR   GDSC; 1330972

DR   GEO; GSM887387

DR   GEO; GSM888465

DR   GEO; GSM986179

DR   GEO; GSM1670198

DR   GEO; GSM1682808

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A513 ! NCI-H1881

OI   CVCL_1504 ! NCI-H1882

SX   Male

CA   Cancer cell line

//

ID   NCI-H1881

AC   CVCL_A513

SY   H1881; H-1881

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1503 ! NCI-H1876

OI   CVCL_1504 ! NCI-H1882

SX   Male

CA   Cancer cell line

//

ID   NCI-H1882

AC   CVCL_1504

SY   H1882; H-1882

DR   CLO; CLO_0008028

DR   EFO; EFO_0006665

DR   ATCC; CRL-5903

DR   BioSample; SAMN03473011

DR   ChEMBL-Cells; CHEMBL3308318

DR   ChEMBL-Targets; CHEMBL2366210

DR   Cosmic; 753602

DR   Cosmic; 877228

DR   Cosmic; 980954

DR   Cosmic; 1032425

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 18

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 12,14

ST   FGA: 21,24

ST   Penta D: 12,13

ST   Penta E: 13

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1503 ! NCI-H1876

OI   CVCL_A513 ! NCI-H1881

SX   Male

CA   Cancer cell line

//

ID   NCI-H1904

AC   CVCL_A514

SY   H1904; H-1904

RX   PubMed=8806092;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1915

AC   CVCL_1505

SY   H1915; H-1915

DR   BTO; BTO:0004426

DR   CLO; CLO_0008029

DR   EFO; EFO_0006666

DR   ATCC; CRL-5904

DR   BioSample; SAMN03473019

DR   CCLE; NCIH1915_LUNG

DR   Cosmic; 722067

DR   Cosmic; 1146892

DR   Cosmic; 1995545

DR   Cosmic-CLP; 1240184

DR   GDSC; 1240184

DR   GEO; GSM434314

DR   GEO; GSM827393

DR   GEO; GSM887388

DR   GEO; GSM888466

DR   GEO; GSM1670199

DR   IGRhCellID; H1915GEO

DR   KCLB; 91915

DR   LINCS; 50035

DR   PRIDE; PXD002556

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 91915; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9

ST   D18S51: 11

ST   D21S11: 27

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 10

ST   FGA: 20

ST   Penta D: 13

ST   Penta E: 10

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1926

AC   CVCL_1506

SY   H1926; H-1926

DR   CLO; CLO_0008030

DR   ATCC; CRL-5905

DR   BioSample; SAMN03472593

DR   Cosmic; 688008

DR   Cosmic; 850432

DR   Cosmic; 908477

DR   GDSC; 908477

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20679594;

ST   Source(s): ATCC; PubMed=20679594

ST   Amelogenin: X (ATCC)

ST   Amelogenin: X,Y (PubMed=20679594)

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 11,12

ST   D5S818: 13

ST   D7S820: 10,12

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1930

AC   CVCL_1507

SY   H1930; H-1930

DR   CLO; CLO_0008031

DR   EFO; EFO_0002270

DR   ATCC; CRL-5906

DR   BioSample; SAMN03473063

DR   CCLE; NCIH1930_LUNG

DR   Cosmic; 688009

DR   Cosmic; 844575

DR   Cosmic; 877229

DR   Cosmic; 924245

DR   Cosmic; 2125238

DR   GEO; GSM380480

DR   GEO; GSM887389

DR   GEO; GSM888467

DR   IGRhCellID; NCIH1930

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 11

ST   D18S51: 12,19

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 9,10

ST   D8S1179: 12,14

ST   FGA: 21

ST   Penta D: 11

ST   Penta E: 7,13

ST   TH01: 6,10

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1934

AC   CVCL_A515

SY   H1934; H-1934

RX   PubMed=8806092;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1944

AC   CVCL_1508

SY   H1944; H-1944

DR   BTO; BTO:0005837

DR   CLO; CLO_0008032

DR   EFO; EFO_0006667

DR   ATCC; CRL-5907

DR   BioSample; SAMN03473281

DR   CCLE; NCIH1944_LUNG

DR   Cosmic; 722062

DR   Cosmic; 903606

DR   Cosmic; 1146893

DR   Cosmic; 1891897

DR   Cosmic-CLP; 1240185

DR   GDSC; 1240185

DR   GEO; GSM434331

DR   GEO; GSM513950

DR   GEO; GSM514335

DR   GEO; GSM794339

DR   GEO; GSM827486

DR   GEO; GSM887390

DR   GEO; GSM888468

DR   GEO; GSM1670200

DR   IGRhCellID; H1944GEO

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 18,19

ST   D21S11: 28,31

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 11,12

ST   D8S1179: 14,15

ST   FGA: 21,25

ST   Penta D: 8,11

ST   Penta E: 5,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1954

AC   CVCL_A516

SY   H1954; H-1954

RX   PubMed=8806092;

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H196

AC   CVCL_1509

SY   H196; H-196; NCIH196

DR   BTO; BTO:0003027

DR   CLO; CLO_0008033

DR   EFO; EFO_0006668

DR   ATCC; CRL-5823

DR   BioSample; SAMN03471881

DR   CCLE; NCIH196_LUNG

DR   Cosmic; 852003

DR   Cosmic; 953990

DR   Cosmic; 1995546

DR   Cosmic-CLP; 1240186

DR   GDSC; 1240186

DR   GEO; GSM169451

DR   GEO; GSM784210

DR   GEO; GSM827362

DR   GEO; GSM845541

DR   GEO; GSM844633

DR   GEO; GSM887392

DR   GEO; GSM888470

DR   GEO; GSM986170

DR   GEO; GSM1670201

DR   KCLB; 90196

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 64 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90196; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11

ST   D18S51: 17,19

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 22,23

ST   Penta D: 10

ST   Penta E: 8,12

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1963

AC   CVCL_1510

SY   H1963; H-1963; NCIH1963

DR   BTO; BTO:0005976

DR   CLO; CLO_0008034

DR   ATCC; CRL-5982

DR   BioSample; SAMN03472631

DR   BioSample; SAMN03473530

DR   CCLE; NCIH1963_LUNG

DR   ChEMBL-Cells; CHEMBL3308855

DR   ChEMBL-Targets; CHEMBL2366075

DR   Cosmic; 688010

DR   Cosmic; 877230

DR   Cosmic; 1021880

DR   Cosmic; 1219106

DR   Cosmic; 1239945

DR   Cosmic; 1995547

DR   Cosmic; 2125206

DR   Cosmic-CLP; 688010

DR   DSMZ; ACC-540

DR   GDSC; 688010

DR   GEO; GSM169429

DR   GEO; GSM845542

DR   GEO; GSM844634

DR   GEO; GSM844635

DR   GEO; GSM887391

DR   GEO; GSM888469

DR   GEO; GSM1670202

DR   GEO; GSM1682809

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~3-4 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP)

ST   Amelogenin: X (DSMZ)

ST   CSF1PO: 12

ST   D13S317: 11,13

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 6,8

ST   TPOX: 8,10

ST   vWA: 17,20

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E101 ! NCI-BL1963

SX   Male

CA   Cancer cell line

//

ID   NCI-H1968

AC   CVCL_A517

SY   H1968; H-1968

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1971

AC   CVCL_A518

SY   H1971; H-1971

RX   PubMed=8806092;

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1974

AC   CVCL_A519

SY   H1974; H-1974

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1975

AC   CVCL_1511

SY   H1975; H-1975

DR   BTO; BTO:0004824

DR   CLO; CLO_0008035

DR   EFO; EFO_0002271

DR   CLDB; cl7204

DR   ATCC; CRL-5908

DR   BCRJ; 0352

DR   BioSample; SAMN03471753

DR   BioSample; SAMN03472594

DR   CCLE; NCIH1975_LUNG

DR   CCRID; 3111C0001CCC000252

DR   ChEMBL-Cells; CHEMBL3307601

DR   ChEMBL-Targets; CHEMBL614348

DR   Cosmic; 687808

DR   Cosmic; 903607

DR   Cosmic; 924244

DR   Cosmic; 930487

DR   Cosmic; 1028949

DR   Cosmic; 1047098

DR   Cosmic; 1128244

DR   Cosmic; 1146894

DR   Cosmic; 1154595

DR   Cosmic; 1336879

DR   Cosmic; 1513408

DR   Cosmic; 1571739

DR   Cosmic; 1609518

DR   Cosmic; 1741781

DR   Cosmic; 1795297

DR   Cosmic; 1802294

DR   Cosmic; 1995548

DR   Cosmic; 2042865

DR   Cosmic; 2125194

DR   Cosmic-CLP; 924244

DR   GDSC; 924244

DR   GEO; GSM206481

DR   GEO; GSM253304

DR   GEO; GSM434293

DR   GEO; GSM513951

DR   GEO; GSM514336

DR   GEO; GSM782116

DR   GEO; GSM794340

DR   GEO; GSM887393

DR   GEO; GSM888471

DR   GEO; GSM1374716

DR   GEO; GSM1670203

DR   ICLC; HTL06001

DR   IGRhCellID; NCIH1975

DR   KCB; KCB 2014034YJ

DR   PRIDE; PXD002224

RX   PubMed=8806092;

RX   PubMed=19727395;

RX   PubMed=21498706;

RX   PubMed=22460905;

RX   PubMed=25008024;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26202522;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 38.7 +- 5.92 hours (PubMed=25008024); 28 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep membrane proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,13 (ATCC; Cosmic-CLP)

ST   D13S317: 10 (PubMed=25877200)

ST   D16S539: 9,12

ST   D18S51: 13

ST   D21S11: 28

ST   D3S1358: 14,15

ST   D5S818: 11,12

ST   D7S820: 8,11 (ATCC)

ST   D7S820: 8 (Cosmic-CLP; PubMed=25877200)

ST   D8S1179: 13,16

ST   FGA: 21,24

ST   Penta D: 12,13

ST   Penta E: 12,16

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H1975-Luc

AC   CVCL_4W96

DR   JCRB; JCRB1486

DR   JCRB; NIHS0724

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,13

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1511 ! NCI-H1975

SX   Female

CA   Cancer cell line

//

ID   NCI-H1975/GR

AC   CVCL_HF59

RX   PubMed=25008024;

CC   Doubling time: 47.73 +- 3.50 hours (PubMed=25008024).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1511 ! NCI-H1975

SX   Female

CA   Cancer cell line

//

ID   NCI-H1975/GR/XR

AC   CVCL_HF60

RX   PubMed=25008024;

CC   Doubling time: 46.68 +- 2.68 hours (PubMed=25008024).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Transformant: NCIt; C17262; X-Ray.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_HF59 ! NCI-H1975/GR

SX   Female

CA   Cancer cell line

//

ID   NCI-H1977

AC   CVCL_A520

SY   H1977; H-1977

RX   PubMed=8806092;

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H1993

AC   CVCL_1512

SY   H1993; H-1993

DR   CLO; CLO_0008036

DR   EFO; EFO_0002272

DR   ATCC; CRL-5909

DR   BioSample; SAMN03473255

DR   ChEMBL-Cells; CHEMBL3308138

DR   ChEMBL-Targets; CHEMBL1075527

DR   Cosmic; 687809

DR   Cosmic; 877248

DR   Cosmic; 903608

DR   Cosmic; 908476

DR   Cosmic; 980988

DR   Cosmic; 1032460

DR   Cosmic; 1146895

DR   Cosmic; 1694669

DR   Cosmic; 1870266

DR   Cosmic; 1891898

DR   Cosmic; 1995549

DR   Cosmic; 2125239

DR   Cosmic-CLP; 908476

DR   GDSC; 908476

DR   GEO; GSM62328

DR   GEO; GSM434315

DR   GEO; GSM513952

DR   GEO; GSM514337

DR   GEO; GSM794341

DR   GEO; GSM1670204

DR   IGRhCellID; NCIH1993

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=24297535;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X (ATCC; Cosmic-CLP; PubMed=25877200)

ST   Amelogenin: X,Y (PubMed=20679594)

ST   CSF1PO: 10,13

ST   D13S317: 13

ST   D16S539: 12

ST   D18S51: 13,18

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 12

ST   D8S1179: 14

ST   FGA: 22,23

ST   Penta D: 10

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E102 ! NCI-BL1993

OI   CVCL_1521 ! NCI-H2073

SX   Female

CA   Cancer cell line

//

ID   NCI-H1994

AC   CVCL_1513

SY   H1994; H-1994

DR   CLO; CLO_0008037

DR   ATCC; CRL-5910

DR   BioSample; SAMN03472595

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Discontinued: ATCC; CRL-5910; true.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1516 ! NCI-H2029

SX   Female

CA   Cancer cell line

//

ID   NCI-H2007

AC   CVCL_A521

SY   H2007; H-2007

RX   PubMed=8806092;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2009

AC   CVCL_1514

SY   H2009; H-2009

DR   BTO; BTO:0003242

DR   CLO; CLO_0008038

DR   EFO; EFO_0002273

DR   ATCC; CRL-5911

DR   BioSample; SAMN03471794

DR   CCLE; NCIH2009_LUNG

DR   CCRID; 3111C0001CCC000383

DR   ChEMBL-Cells; CHEMBL3308459

DR   ChEMBL-Targets; CHEMBL1075528

DR   Cosmic; 722054

DR   Cosmic; 724873

DR   Cosmic; 877249

DR   Cosmic; 877436

DR   Cosmic; 903609

DR   Cosmic; 980989

DR   Cosmic; 1032461

DR   Cosmic; 1146896

DR   Cosmic; 1154596

DR   Cosmic; 1188589

DR   Cosmic; 1239889

DR   Cosmic; 1518084

DR   Cosmic; 1802308

DR   Cosmic; 1870267

DR   Cosmic; 1891899

DR   Cosmic; 1995550

DR   Cosmic; 2125240

DR   Cosmic-CLP; 724873

DR   GDSC; 724873

DR   GEO; GSM63697

DR   GEO; GSM206482

DR   GEO; GSM253369

DR   GEO; GSM385518

DR   GEO; GSM385529

DR   GEO; GSM434316

DR   GEO; GSM794342

DR   GEO; GSM827528

DR   GEO; GSM887394

DR   GEO; GSM888472

DR   GEO; GSM1670205

DR   IGRhCellID; NCIH2009

DR   KCLB; 92009

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2009.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 10,15

ST   FGA: 22 (KCLB; PubMed=25877200)

ST   FGA: 22,26 (PubMed=11416159)

ST   Penta D: 12

ST   Penta E: 11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2645 ! NCI-BL2009

SX   Female

CA   Cancer cell line

//

ID   NCI-H2009-Luc

AC   CVCL_4Y15

DR   JCRB; NIHS0725

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1514 ! NCI-H2009

SX   Female

CA   Cancer cell line

//

ID   NCI-H2023

AC   CVCL_1515

SY   H2023; H-2023

DR   CLO; CLO_0008039

DR   EFO; EFO_0006669

DR   ATCC; CRL-5912

DR   BioSample; SAMN03472596

DR   BioSample; SAMN03472996

DR   CCLE; NCIH2023_LUNG

DR   Cosmic; 903610

DR   Cosmic; 1995551

DR   Cosmic-CLP; 1240187

DR   GDSC; 1240187

DR   GEO; GSM513953

DR   GEO; GSM514338

DR   GEO; GSM784271

DR   GEO; GSM794343

DR   GEO; GSM827487

DR   GEO; GSM887395

DR   GEO; GSM888473

DR   GEO; GSM1670206

DR   LINCS; 50036

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 17,18

ST   D21S11: 29,33.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 10,13

ST   FGA: 21,22

ST   Penta D: 9,13

ST   Penta E: 16

ST   TH01: 7,9 (ATCC; Cosmic-CLP)

ST   TH01: 7,9,9.1 (PubMed=25877200)

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2028

AC   CVCL_A522

SY   H2028; H-2028

DR   Cosmic; 1518104

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2646 ! NCI-BL2028

SX   Male

CA   Cancer cell line

//

ID   NCI-H2029

AC   CVCL_1516

SY   H2029; H-2029

DR   BTO; BTO:0005977

DR   CLO; CLO_0008040

DR   ATCC; CRL-5913

DR   CCLE; NCIH2029_LUNG

DR   ChEMBL-Cells; CHEMBL3308473

DR   ChEMBL-Targets; CHEMBL1075529

DR   Cosmic; 688011

DR   Cosmic; 1995552

DR   Cosmic; 2125207

DR   Cosmic-CLP; 688011

DR   GDSC; 688011

DR   GEO; GSM887396

DR   GEO; GSM888474

DR   GEO; GSM1670207

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,14

ST   D16S539: 12

ST   D3S1358: Not_detected

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   TH01: 6,9.3 (ATCC)

ST   TH01: 7,9.3 (Cosmic-CLP; PubMed=20679594)

ST   TPOX: 8

ST   vWA: 15,20 (ATCC)

ST   vWA: 15,19 (Cosmic-CLP; PubMed=20679594)

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1513 ! NCI-H1994

SX   Female

CA   Cancer cell line

//

ID   NCI-H2030

AC   CVCL_1517

SY   H2030; H-2030

DR   CLO; CLO_0008041

DR   EFO; EFO_0002274

DR   ATCC; CRL-5914

DR   BioSample; SAMN03471413

DR   CCLE; NCIH2030_LUNG

DR   ChEMBL-Cells; CHEMBL3308769

DR   ChEMBL-Targets; CHEMBL1075530

DR   Cosmic; 722045

DR   Cosmic; 903611

DR   Cosmic; 1146897

DR   Cosmic; 1609520

DR   Cosmic; 1995553

DR   Cosmic-CLP; 722045

DR   GDSC; 722045

DR   GEO; GSM206483

DR   GEO; GSM434332

DR   GEO; GSM784272

DR   GEO; GSM794344

DR   GEO; GSM887397

DR   GEO; GSM888475

DR   GEO; GSM1374717

DR   GEO; GSM1670208

DR   IGRhCellID; NCIH2030

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 17,18

ST   D21S11: 30

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 11,15

ST   FGA: 20,24

ST   Penta D: 9

ST   Penta E: 11,15

ST   TH01: 9.3

ST   TPOX: 9,12

ST   vWA: 15

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2052

AC   CVCL_1518

SY   H2052; H-2052; H2052_MM; NCIH2052

DR   CLO; CLO_0008042

DR   EFO; EFO_0002275

DR   ATCC; CRL-5915

DR   BioSample; SAMN03471041

DR   BioSample; SAMN03472597

DR   CCLE; NCIH2052_PLEURA

DR   CCRID; 3111C0001CCC000289

DR   ChEMBL-Cells; CHEMBL3308119

DR   ChEMBL-Targets; CHEMBL1075531

DR   Cosmic; 688058

DR   Cosmic; 877272

DR   Cosmic; 877437

DR   Cosmic; 886390

DR   Cosmic; 980998

DR   Cosmic; 1032389

DR   Cosmic; 1146898

DR   Cosmic; 1481545

DR   Cosmic; 1522774

DR   Cosmic; 1541213

DR   Cosmic; 1571797

DR   Cosmic; 1749565

DR   Cosmic; 1891920

DR   Cosmic; 1963327

DR   Cosmic; 1995554

DR   Cosmic; 2474148

DR   Cosmic-CLP; 688058

DR   GDSC; 688058

DR   GEO; GSM434305

DR   GEO; GSM726264

DR   GEO; GSM794345

DR   GEO; GSM887398

DR   GEO; GSM888476

DR   GEO; GSM1670209

DR   IGRhCellID; H2052_MMGEO

DR   IGRhCellID; NCIH2052

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=21642991;

RX   PubMed=22460905;

RX   PubMed=23830731;

RX   PubMed=24926545;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 48 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 17

ST   D21S11: 32.2

ST   D3S1358: 14,15

ST   D5S818: 11

ST   D7S820: 12 (ATCC; Cosmic-CLP)

ST   D7S820: 11,12 (PubMed=25877200)

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 10

ST   Penta E: 12,16

ST   TH01: 7,9.3

ST   TPOX: 8,11 (ATCC; Cosmic-CLP)

ST   TPOX: 8 (PubMed=25877200)

ST   vWA: 17

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2647 ! NCI-BL2052

SX   Male

CA   Cancer cell line

//

ID   NCI-H2058

AC   CVCL_A523

SY   H2058; H-2058

DR   Cosmic; 877438

RX   PubMed=8806092;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2059

AC   CVCL_1519

SY   H2059; H-2059

DR   CLO; CLO_0008043

DR   ATCC; CRL-5916

DR   BioSample; SAMN03472598

DR   Cosmic; 753603

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Discontinued: ATCC; CRL-5916; true.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 14

ST   D16S539: 8

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 8

ST   TPOX: 8,9

ST   vWA: 19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1534 ! NCI-H2141

OI   CVCL_2653 ! NCI-BL2141

SX   Male

CA   Cancer cell line

//

ID   NCI-H2066

AC   CVCL_1520

SY   H2066; H-2066; NCIH2066

DR   CLO; CLO_0008044

DR   ATCC; CRL-5917

DR   BioSample; SAMN03472599

DR   CCLE; NCIH2066_LUNG

DR   Cosmic-CLP; 1330973

DR   GDSC; 1330973

DR   GEO; GSM434788

DR   GEO; GSM887399

DR   GEO; GSM888477

DR   GEO; GSM1374718

DR   GEO; GSM1670210

DR   KCLB; 92066

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 92066; probable.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 14

ST   D13S317: 12

ST   D16S539: 12,13

ST   D5S818: 13

ST   D7S820: 10,12

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2073

AC   CVCL_1521

SY   H2073; H-2073

DR   CLO; CLO_0008045

DR   EFO; EFO_0006670

DR   ATCC; CRL-5918

DR   BioSample; SAMN03473292

DR   CCLE; NCIH2073_LUNG

DR   Cosmic; 687811

DR   Cosmic; 903612

DR   Cosmic; 1146899

DR   Cosmic; 1870268

DR   GEO; GSM253368

DR   GEO; GSM513954

DR   GEO; GSM514339

DR   GEO; GSM794346

DR   GEO; GSM888478

DR   GEO; GSM1374719

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=24297535;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 13

ST   D16S539: 12

ST   D18S51: 13,18

ST   D21S11: 29

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 12

ST   D8S1179: 12,14

ST   FGA: 22,23

ST   Penta D: 10

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E102 ! NCI-BL1993

OI   CVCL_1512 ! NCI-H1993

SX   Female

CA   Cancer cell line

//

ID   NCI-H2077

AC   CVCL_5157

SY   H2077; H-2077

DR   ATCC; CRL-5919

DR   Cosmic; 877250

DR   Cosmic; 877439

DR   Cosmic; 903613

DR   Cosmic; 980990

DR   Cosmic; 1032462

DR   GEO; GSM434269

DR   GEO; GSM794347

DR   IGRhCellID; H2077GEO

DR   PRIDE; PXD002556

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=26361996;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep proteome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5919; true.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E103 ! NCI-BL2077

SX   Male

CA   Cancer cell line

//

ID   NCI-H2081

AC   CVCL_1522

SY   H2081; H-2081

DR   CLO; CLO_0008046

DR   EFO; EFO_0002276

DR   ATCC; CRL-5920

DR   BioSample; SAMN03472952

DR   CCLE; NCIH2081_LUNG

DR   ChEMBL-Cells; CHEMBL3308319

DR   ChEMBL-Targets; CHEMBL2366082

DR   Cosmic; 688012

DR   Cosmic; 877385

DR   Cosmic; 908480

DR   Cosmic; 980955

DR   Cosmic; 1032426

DR   Cosmic; 1891915

DR   Cosmic; 1995555

DR   Cosmic; 2125241

DR   Cosmic-CLP; 908480

DR   GDSC; 908480

DR   GEO; GSM827527

DR   GEO; GSM887400

DR   GEO; GSM888479

DR   GEO; GSM1670211

DR   IGRhCellID; NCIH2081

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'NCI-H2018' in Cosmic 877385.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 13,14

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 10

ST   D7S820: 8,10

ST   D8S1179: 14,15

ST   FGA: 20

ST   Penta D: 12

ST   Penta E: 7,12

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2085

AC   CVCL_1523

SY   H2085; H-2085

DR   CLO; CLO_0008047

DR   ATCC; CRL-5921

DR   BioSample; SAMN03472600

DR   CCLE; NCIH2085_LUNG

DR   Cosmic; 687812

DR   Cosmic; 1995556

DR   Cosmic-CLP; 687812

DR   GDSC; 687812

DR   GEO; GSM513955

DR   GEO; GSM514340

DR   GEO; GSM784273

DR   GEO; GSM794348

DR   GEO; GSM827509

DR   GEO; GSM887401

DR   GEO; GSM888480

DR   GEO; GSM1374720

DR   GEO; GSM1670212

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 13

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,19

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2086

AC   CVCL_A524

SY   H2086; H-2086

DR   GEO; GSM794349

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D16S539: 13

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 15,19,20

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2087

AC   CVCL_1524

SY   H2087; H-2087

DR   BTO; BTO:0003241

DR   CLO; CLO_0008048

DR   EFO; EFO_0002277

DR   ATCC; CRL-5922

DR   BioSample; SAMN03472602

DR   CCLE; NCIH2087_LUNG

DR   CCRID; 3111C0001CCC000253

DR   ChEMBL-Cells; CHEMBL3308770

DR   ChEMBL-Targets; CHEMBL1075532

DR   Cosmic; 724834

DR   Cosmic; 877251

DR   Cosmic; 877440

DR   Cosmic; 903614

DR   Cosmic; 917389

DR   Cosmic; 961840

DR   Cosmic; 980991

DR   Cosmic; 1006536

DR   Cosmic; 1032463

DR   Cosmic; 1146900

DR   Cosmic; 1152516

DR   Cosmic; 1209730

DR   Cosmic; 1219085

DR   Cosmic; 1239890

DR   Cosmic; 1477422

DR   Cosmic; 1518086

DR   Cosmic; 1891900

DR   Cosmic; 1925847

DR   Cosmic; 1995557

DR   Cosmic; 2125242

DR   Cosmic-CLP; 724834

DR   GDSC; 724834

DR   GEO; GSM62329

DR   GEO; GSM253370

DR   GEO; GSM434306

DR   GEO; GSM513956

DR   GEO; GSM514341

DR   GEO; GSM794350

DR   GEO; GSM887402

DR   GEO; GSM888481

DR   GEO; GSM1670213

DR   IGRhCellID; NCIH2087

DR   KCLB; 25922

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2087.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=11416159; PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,11

ST   D18S51: 14

ST   D21S11: 30,32.2

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 10,12

ST   FGA: 20

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2648 ! NCI-BL2087

SX   Male

CA   Cancer cell line

//

ID   NCI-H209

AC   CVCL_1525

SY   H209; H-209; NCIH209

DR   BTO; BTO:0003020

DR   CLO; CLO_0008049

DR   EFO; EFO_0006671

DR   ATCC; HTB-172

DR   BCRC; 60123

DR   BioSample; SAMN03473244

DR   CCLE; NCIH209_LUNG

DR   CCRID; 3111C0001CCC000045

DR   ChEMBL-Cells; CHEMBL3308293

DR   ChEMBL-Targets; CHEMBL2366365

DR   CLS; 300183/p743_NCI-H209

DR   Cosmic; 688013

DR   Cosmic; 755463

DR   Cosmic; 801617

DR   Cosmic; 808317

DR   Cosmic; 808396

DR   Cosmic; 844819

DR   Cosmic; 850429

DR   Cosmic; 876165

DR   Cosmic; 877202

DR   Cosmic; 897518

DR   Cosmic; 1004691

DR   Cosmic; 1021855

DR   Cosmic; 1219100

DR   Cosmic; 1239937

DR   Cosmic; 1518090

DR   Cosmic; 1891903

DR   Cosmic; 2125243

DR   Cosmic; 2239097

DR   Cosmic; 2301573

DR   Cosmic-CLP; 688013

DR   DSMZ; ACC-499

DR   GDSC; 688013

DR   GEO; GSM169438

DR   GEO; GSM380511

DR   GEO; GSM784248

DR   GEO; GSM794276

DR   GEO; GSM845543

DR   GEO; GSM844636

DR   GEO; GSM887403

DR   GEO; GSM888482

DR   GEO; GSM1374721

DR   GEO; GSM1670214

DR   IGRhCellID; NCIH209

DR   KCB; KCB 200816YJ

DR   KCLB; 30172

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=7736387;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=9559344;

RX   PubMed=9815546;

RX   PubMed=10037197;

RX   PubMed=10987304;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=14762065;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=20016488;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H209.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~50-70 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Genome sequenced.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 9,12

ST   D18S51: 13

ST   D21S11: 32.2

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 9

ST   D8S1179: 12,13

ST   FGA: 20,24

ST   Penta D: 11,12

ST   Penta E: 11,12

ST   TH01: 7,9

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2649 ! NCI-BL209

SX   Male

CA   Cancer cell line

//

ID   NCI-H2106

AC   CVCL_1526

SY   NCI H2106; H2106; H-2106

DR   CLO; CLO_0008050

DR   EFO; EFO_0006672

DR   ATCC; CRL-5923

DR   BioSample; SAMN03473266

DR   CCLE; NCIH2106_LUNG

DR   Cosmic; 687813

DR   GEO; GSM794351

DR   GEO; GSM887404

DR   GEO; GSM888483

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 13

ST   D16S539: 12,13

ST   D18S51: 14,16

ST   D19S433: 13,14

ST   D21S11: 30,32.2

ST   D2S1338: 17,23

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 20

ST   Penta D: 9,10

ST   Penta E: 7,12

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 18,19

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2107

AC   CVCL_1527

SY   H2107; H-2107; NCIH2107

DR   CLO; CLO_0008051

DR   EFO; EFO_0002278

DR   ATCC; CRL-5983

DR   ATCC; CRL-5983_FL

DR   BioSample; SAMN03472632

DR   ChEMBL-Cells; CHEMBL3308879

DR   ChEMBL-Targets; CHEMBL2366122

DR   Cosmic; 877231

DR   Cosmic; 877386

DR   Cosmic; 924246

DR   Cosmic; 980956

DR   Cosmic; 1021881

DR   Cosmic; 1032427

DR   Cosmic; 1219107

DR   Cosmic; 1239946

DR   Cosmic; 1518091

DR   Cosmic; 1891916

DR   Cosmic; 2125208

DR   GDSC; 924246

DR   GEO; GSM794352

DR   GEO; GSM845544

DR   GEO; GSM844637

DR   IGRhCellID; NCIH2107

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5983; true.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D16S539: 10,13

ST   D5S818: 14

ST   D7S820: 8

ST   TH01: 6,7

ST   TPOX: 10,11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2650 ! NCI-BL2107

OI   CVCL_1528 ! NCI-H2108

SX   Male

CA   Cancer cell line

//

ID   NCI-H2108

AC   CVCL_1528

SY   H2108; H-2108

DR   CLO; CLO_0008052

DR   ATCC; CRL-5984

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D16S539: 10,13

ST   D5S818: 14

ST   D7S820: 8

ST   TH01: 6,7

ST   TPOX: 10,11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2650 ! NCI-BL2107

OI   CVCL_1527 ! NCI-H2107

SX   Male

CA   Cancer cell line

//

ID   NCI-H211

AC   CVCL_1529

SY   H211; H-211

DR   BTO; BTO:0004427

DR   CLO; CLO_0008053

DR   ATCC; CRL-5824

DR   BioSample; SAMN03473064

DR   CCLE; NCIH211_LUNG

DR   Cosmic; 844550

DR   Cosmic; 877203

DR   Cosmic; 980930

DR   Cosmic; 1021856

DR   Cosmic; 1032396

DR   Cosmic; 1152464

DR   Cosmic; 1995558

DR   Cosmic-CLP; 1240189

DR   GDSC; 1240189

DR   GEO; GSM169440

DR   GEO; GSM784209

DR   GEO; GSM794277

DR   GEO; GSM887406

DR   GEO; GSM888485

DR   GEO; GSM986171

DR   GEO; GSM1670215

DR   KCLB; 90211

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90211; probable.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 13

ST   D18S51: 14

ST   D21S11: 30

ST   D3S1358: 18

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 12,14

ST   FGA: 22

ST   Penta D: 9,13

ST   Penta E: 12,15

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 14,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2110

AC   CVCL_1530

SY   H2110; H-2110

DR   CLO; CLO_0008054

DR   EFO; EFO_0006673

DR   ATCC; CRL-5924

DR   BioSample; SAMN03473198

DR   CCLE; NCIH2110_LUNG

DR   Cosmic; 1146901

DR   Cosmic-CLP; 1298351

DR   GDSC; 1298351

DR   GEO; GSM434270

DR   GEO; GSM887405

DR   GEO; GSM888484

DR   GEO; GSM1670216

DR   IGRhCellID; H2110GEO

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 16

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 14

ST   FGA: 22,24

ST   Penta D: 9,11

ST   Penta E: 8,13

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   NCI-H2115

AC   CVCL_E104

SY   H2115; H-2115

RX   PubMed=8806092;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2122

AC   CVCL_1531

SY   H2122; H-2122; NCIH2122

DR   BTO; BTO:0003006

DR   CLO; CLO_0008055

DR   EFO; EFO_0002279

DR   ATCC; CRL-5985

DR   BioSample; SAMN03473110

DR   CCLE; NCIH2122_LUNG

DR   ChEMBL-Cells; CHEMBL3308771

DR   ChEMBL-Targets; CHEMBL1075533

DR   Cosmic; 722046

DR   Cosmic; 850435

DR   Cosmic; 877252

DR   Cosmic; 877441

DR   Cosmic; 903615

DR   Cosmic; 1028947

DR   Cosmic; 1146902

DR   Cosmic; 1152517

DR   Cosmic; 1219086

DR   Cosmic; 1239891

DR   Cosmic; 1320182

DR   Cosmic; 1518085

DR   Cosmic; 1694665

DR   Cosmic; 1870269

DR   Cosmic; 1891901

DR   Cosmic; 1995559

DR   Cosmic; 2125195

DR   Cosmic-CLP; 722046

DR   GDSC; 722046

DR   GEO; GSM62330

DR   GEO; GSM206484

DR   GEO; GSM253371

DR   GEO; GSM434253

DR   GEO; GSM513957

DR   GEO; GSM514342

DR   GEO; GSM784219

DR   GEO; GSM794353

DR   GEO; GSM827526

DR   GEO; GSM887407

DR   GEO; GSM888486

DR   GEO; GSM1374722

DR   GEO; GSM1374723

DR   GEO; GSM1670217

DR   IGRhCellID; NCIH2122

DR   KCLB; 92122

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2122.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 27 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 9,12

ST   D18S51: 19

ST   D21S11: 33.2

ST   D3S1358: 15,16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 13

ST   FGA: 19,26

ST   Penta D: 10,12

ST   Penta E: 11,14

ST   TH01: 7,9.3

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2651 ! NCI-BL2122

SX   Female

CA   Cancer cell line

//

ID   NCI-H2126

AC   CVCL_1532

SY   H2126; H-2126

DR   BTO; BTO:0003240

DR   CLO; CLO_0008056

DR   EFO; EFO_0002280

DR   ATCC; CCL-256

DR   ATCC; CRL-5925

DR   BioSample; SAMN03471320

DR   BioSample; SAMN03471386

DR   CCLE; NCIH2126_LUNG

DR   ChEMBL-Cells; CHEMBL3308894

DR   ChEMBL-Targets; CHEMBL2366160

DR   Cosmic; 687814

DR   Cosmic; 877266

DR   Cosmic; 903616

DR   Cosmic; 961841

DR   Cosmic; 1006537

DR   Cosmic; 1146903

DR   Cosmic; 1219066

DR   Cosmic; 1239892

DR   Cosmic; 1995560

DR   Cosmic; 2125182

DR   Cosmic-CLP; 687814

DR   GDSC; 687814

DR   GEO; GSM206485

DR   GEO; GSM253405

DR   GEO; GSM353228

DR   GEO; GSM434271

DR   GEO; GSM513958

DR   GEO; GSM514343

DR   GEO; GSM784235

DR   GEO; GSM794354

DR   GEO; GSM887408

DR   GEO; GSM888487

DR   GEO; GSM1374724

DR   GEO; GSM1670218

DR   IGRhCellID; NCIH2126

DR   PRIDE; PXD002556

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=14762065;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=26361996;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2126.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5925; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12,14

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 8,9 (ATCC; Cosmic-CLP)

ST   D7S820: 9 (PubMed=25877200)

ST   D8S1179: 12

ST   FGA: 26

ST   Penta D: 10

ST   Penta E: 7,10

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2652 ! NCI-BL2126

SX   Male

CA   Cancer cell line

//

ID   NCI-H2127

AC   CVCL_A525

SY   H2127; H-2127

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2135

AC   CVCL_1533

SY   H2135; H-2135

DR   CLO; CLO_0008057

DR   EFO; EFO_0006674

DR   ATCC; CRL-5926

DR   BioSample; SAMN03472997

DR   Cosmic-CLP; 1298352

DR   GDSC; 1298352

DR   GEO; GSM827510

DR   GEO; GSM1374725

DR   GEO; GSM1670219

RX   PubMed=8806092;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 12

ST   D21S11: 29

ST   D3S1358: 16,17

ST   D5S818: 12,13

ST   D7S820: 11,12

ST   D8S1179: 13,14

ST   FGA: 23

ST   Penta D: 8

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Cancer cell line

//

ID   NCI-H2141

AC   CVCL_1534

SY   H2141; H-2141; NCIH2141

DR   CLO; CLO_0008058

DR   ATCC; CRL-5927

DR   BioSample; SAMN03472603

DR   CCLE; NCIH2141_LUNG

DR   ChEMBL-Cells; CHEMBL3308556

DR   ChEMBL-Targets; CHEMBL2366323

DR   Cosmic; 688014

DR   Cosmic; 850436

DR   Cosmic; 877232

DR   Cosmic; 877387

DR   Cosmic; 1219108

DR   Cosmic; 1239947

DR   Cosmic; 2125209

DR   Cosmic-CLP; 688014

DR   GDSC; 688014

DR   GEO; GSM794355

DR   GEO; GSM844638

DR   GEO; GSM887409

DR   GEO; GSM888488

DR   GEO; GSM1670220

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594

ST   Amelogenin: X,Y (ATCC; PubMed=20679594)

ST   Amelogenin: X (Cosmic-CLP)

ST   CSF1PO: 11

ST   D13S317: 14

ST   D16S539: 8

ST   D5S818: 12

ST   D7S820: 10,12

ST   TH01: 6,8 (ATCC)

ST   TH01: 8 (PubMed=20679594)

ST   TH01: 8,9.3 (Cosmic-CLP)

ST   TPOX: 8,9

ST   vWA: 19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1519 ! NCI-H2059

OI   CVCL_2653 ! NCI-BL2141

SX   Male

CA   Cancer cell line

//

ID   NCI-H2145

AC   CVCL_A526

SY   H2145; H-2145

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2170

AC   CVCL_1535

SY   H2170; H-2170; NCIH2170

DR   BTO; BTO:0005425

DR   CLO; CLO_0008059

DR   EFO; EFO_0002281

DR   ATCC; CRL-5928

DR   BCRJ; 0271

DR   BioSample; SAMN03471883

DR   CCLE; NCIH2170_LUNG

DR   CCRID; 3111C0001CCC000354

DR   ChEMBL-Cells; CHEMBL3308460

DR   ChEMBL-Targets; CHEMBL1075534

DR   Cosmic; 687815

DR   Cosmic; 1802304

DR   Cosmic; 1995561

DR   Cosmic; 2042870

DR   Cosmic; 2060537

DR   Cosmic; 2125196

DR   Cosmic-CLP; 687815

DR   GDSC; 687815

DR   GEO; GSM62966

DR   GEO; GSM434789

DR   GEO; GSM784214

DR   GEO; GSM794356

DR   GEO; GSM827511

DR   GEO; GSM844639

DR   GEO; GSM887410

DR   GEO; GSM888489

DR   GEO; GSM1670221

DR   IGRhCellID; NCIH2170

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9

ST   D16S539: 12,14

ST   D18S51: 13,14

ST   D21S11: 31.2

ST   D3S1358: 19

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 14

ST   FGA: 25,26

ST   Penta D: 9

ST   Penta E: 7,13

ST   TH01: 8,9.3

ST   TPOX: 8,9

ST   vWA: 15,19

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2171

AC   CVCL_1536

SY   H2171; H-2171; NCIH2171

DR   BTO; BTO:0005978

DR   CLO; CLO_0008060

DR   EFO; EFO_0002282

DR   ATCC; CRL-5929

DR   BioSample; SAMN03471007

DR   CCLE; NCIH2171_LUNG

DR   ChEMBL-Cells; CHEMBL3308320

DR   ChEMBL-Targets; CHEMBL2366213

DR   Cosmic; 688015

DR   Cosmic; 850437

DR   Cosmic; 877233

DR   Cosmic; 877388

DR   Cosmic; 980957

DR   Cosmic; 1021882

DR   Cosmic; 1032428

DR   Cosmic; 1219109

DR   Cosmic; 1239948

DR   Cosmic; 1518087

DR   Cosmic; 1759280

DR   Cosmic; 1891917

DR   Cosmic; 1995562

DR   Cosmic; 2125197

DR   Cosmic-CLP; 688015

DR   DSMZ; ACC-544

DR   GDSC; 688015

DR   GEO; GSM794357

DR   GEO; GSM827525

DR   GEO; GSM887411

DR   GEO; GSM888490

DR   GEO; GSM1670222

DR   IGRhCellID; NCIH2171

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=14762065;

RX   PubMed=16157194;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   http://www.pawefish.path.cam.ac.uk/LungCellLineDescriptions/NCI-H2171.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 40 hours (PubMed=25984343); ~35-60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12,13

ST   D18S51: 18,21

ST   D21S11: 28,32.2

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 11,13

ST   D8S1179: 12

ST   FGA: 22

ST   Penta D: 12

ST   Penta E: 10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2654 ! NCI-BL2171

SX   Male

CA   Cancer cell line

//

ID   NCI-H2172

AC   CVCL_1537

SY   H2172; H-2172

DR   CLO; CLO_0008061

DR   EFO; EFO_0006675

DR   ATCC; CRL-5930

DR   BioSample; SAMN03473020

DR   CCLE; NCIH2172_LUNG

DR   Cosmic; 1146904

DR   Cosmic-CLP; 1298353

DR   GDSC; 1298353

DR   GEO; GSM434294

DR   GEO; GSM794358

DR   GEO; GSM827524

DR   GEO; GSM887412

DR   GEO; GSM888491

DR   GEO; GSM1374726

DR   GEO; GSM1670223

DR   IGRhCellID; H2172GEO

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 15

ST   D21S11: 27

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 12,13

ST   FGA: 19,22

ST   Penta D: 2.2,8

ST   Penta E: 7,13

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 15

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2195

AC   CVCL_1538

SY   H2195; H-2195

DR   CLO; CLO_0008062

DR   EFO; EFO_0002283

DR   ATCC; CRL-5931

DR   Cosmic; 877389

DR   Cosmic; 1219110

DR   Cosmic; 1239949

DR   Cosmic; 1518088

DR   Cosmic; 2125244

DR   GEO; GSM794359

DR   IGRhCellID; NCIH2195

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 10

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2655 ! NCI-BL2195

OI   CVCL_1539 ! NCI-H2196

OI   CVCL_1540 ! NCI-H2198

SX   Male

CA   Cancer cell line

//

ID   NCI-H2196

AC   CVCL_1539

SY   H2196; H-2196

DR   CLO; CLO_0008063

DR   EFO; EFO_0006676

DR   ATCC; CRL-5932

DR   BioSample; SAMN03473226

DR   CCLE; NCIH2196_LUNG

DR   ChEMBL-Cells; CHEMBL3308772

DR   ChEMBL-Targets; CHEMBL1075535

DR   Cosmic; 688016

DR   Cosmic; 877390

DR   Cosmic; 908481

DR   Cosmic; 1995563

DR   Cosmic; 2125245

DR   Cosmic-CLP; 908481

DR   GDSC; 908481

DR   GEO; GSM827562

DR   GEO; GSM887413

DR   GEO; GSM888492

DR   GEO; GSM1670224

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 10

ST   D18S51: 13,14

ST   D21S11: 30

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 9,10

ST   Penta E: 7

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2655 ! NCI-BL2195

OI   CVCL_1538 ! NCI-H2195

OI   CVCL_1540 ! NCI-H2198

SX   Male

CA   Cancer cell line

//

ID   NCI-H2198

AC   CVCL_1540

SY   H2198; H-2198

DR   CLO; CLO_0008064

DR   EFO; EFO_0006677

DR   ATCC; CRL-5933

DR   BioSample; SAMN03473227

DR   Cosmic; 688017

DR   Cosmic; 877234

DR   GEO; GSM986180

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=20679594;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 10

ST   D18S51: 13,14

ST   D21S11: 30

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 10,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 9,10

ST   Penta E: 7

ST   TH01: 9.3

ST   TPOX: 8,9 (ATCC; PubMed=20679594)

ST   TPOX: 8 (PubMed=25877200)

ST   vWA: 18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2655 ! NCI-BL2195

OI   CVCL_1538 ! NCI-H2195

OI   CVCL_1539 ! NCI-H2196

SX   Male

CA   Cancer cell line

//

ID   NCI-H220

AC   CVCL_1541

SY   H220; H-220

DR   CLO; CLO_0008065

DR   ATCC; CRL-5825

DR   BioSample; SAMN03471745

DR   GDSC; 1330974

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 10

ST   D5S818: 11

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2227

AC   CVCL_1542

SY   H2227; H-2227

DR   CLO; CLO_0008066

DR   ATCC; CRL-5934

DR   BioSample; SAMN03473243

DR   CCLE; NCIH2227_LUNG

DR   CCRID; 3111C0001CCC000254

DR   ChEMBL-Cells; CHEMBL3308321

DR   ChEMBL-Targets; CHEMBL2366217

DR   Cosmic; 688018

DR   Cosmic; 877279

DR   Cosmic; 877391

DR   Cosmic; 980958

DR   Cosmic; 1032429

DR   Cosmic; 2125246

DR   Cosmic-CLP; 688018

DR   GDSC; 688018

DR   GEO; GSM794360

DR   GEO; GSM887414

DR   GEO; GSM888493

DR   GEO; GSM1670225

DR   KCLB; 92227

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 92227; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 9

ST   D18S51: 12,13

ST   D21S11: 28,32.2

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 10,12

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 8,15

ST   Penta E: 7,17

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2228

AC   CVCL_1543

SY   H2228; H-2228

DR   CLO; CLO_0008067

DR   EFO; EFO_0002284

DR   ATCC; CRL-5935

DR   BCRJ; 0330

DR   BioSample; SAMN03473167

DR   CCLE; NCIH2228_LUNG

DR   ChEMBL-Cells; CHEMBL3308120

DR   ChEMBL-Targets; CHEMBL1075536

DR   Cosmic; 687816

DR   Cosmic; 897513

DR   Cosmic; 903617

DR   Cosmic; 930491

DR   Cosmic; 1146905

DR   Cosmic; 1609517

DR   Cosmic; 1612226

DR   Cosmic; 1995564

DR   Cosmic-CLP; 687816

DR   GDSC; 687816

DR   GEO; GSM434317

DR   GEO; GSM513959

DR   GEO; GSM514344

DR   GEO; GSM794361

DR   GEO; GSM827512

DR   GEO; GSM887415

DR   GEO; GSM888494

DR   GEO; GSM1374727

DR   GEO; GSM1670226

DR   IGRhCellID; NCIH2228

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=24675041;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'HC2228' in Cosmic 1612226.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D18S51: 16

ST   D21S11: 28,30

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 11

ST   D8S1179: 13

ST   FGA: 21,22

ST   Penta D: 11,13

ST   Penta E: 11,16

ST   TH01: 7,8

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2228-Luc

AC   CVCL_4V13

DR   JCRB; JCRB1492

DR   JCRB; NIHS0726

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11,13

ST   D5S818: 12

ST   D7S820: 11

ST   TH01: 7,8

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1543 ! NCI-H2228

SX   Female

CA   Cancer cell line

//

ID   NCI-H2250

AC   CVCL_A527

SY   H2250; H-2250

DR   ATCC; CRL-5936

DR   GEO; GSM794362

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5936; true.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2258

AC   CVCL_A528

SY   H2258; H-2258

DR   Cosmic; 877442

DR   Cosmic; 980959

DR   Cosmic; 1032430

DR   GEO; GSM794363

RX   PubMed=8806092;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H226

AC   CVCL_1544

SY   NCI.H226; H226; H-226; HUT-226; HUT 226; NCIH226

DR   BTO; BTO:0003008

DR   CLO; CLO_0008068

DR   EFO; EFO_0002285

DR   ATCC; CRL-5826

DR   BioSample; SAMN03471987

DR   CCLE; NCIH226_LUNG

DR   CCRID; 3131C0001001200016

DR   ChEMBL-Cells; CHEMBL3307697

DR   ChEMBL-Targets; CHEMBL614740

DR   Cosmic; 733816

DR   Cosmic; 875850

DR   Cosmic; 877259

DR   Cosmic; 877402

DR   Cosmic; 886388

DR   Cosmic; 903570

DR   Cosmic; 905941

DR   Cosmic; 931374

DR   Cosmic; 974291

DR   Cosmic; 980961

DR   Cosmic; 1006539

DR   Cosmic; 1028953

DR   Cosmic; 1032433

DR   Cosmic; 1047100

DR   Cosmic; 1092618

DR   Cosmic; 1152497

DR   Cosmic; 1175863

DR   Cosmic; 1188585

DR   Cosmic; 1219111

DR   Cosmic; 1239951

DR   Cosmic; 1305346

DR   Cosmic; 1312331

DR   Cosmic; 1436011

DR   Cosmic; 1481544

DR   Cosmic; 1802319

DR   Cosmic; 1870270

DR   Cosmic; 1963326

DR   Cosmic; 1995565

DR   Cosmic; 1998460

DR   Cosmic; 2060522

DR   Cosmic-CLP; 905941

DR   ENCODE; ENCBS328RVB

DR   ENCODE; ENCBS986NWY

DR   GDSC; 905941

DR   GEO; GSM50213

DR   GEO; GSM50276

DR   GEO; GSM62965

DR   GEO; GSM206486

DR   GEO; GSM750820

DR   GEO; GSM794278

DR   GEO; GSM799340

DR   GEO; GSM799403

DR   GEO; GSM847074

DR   GEO; GSM844641

DR   GEO; GSM844640

DR   GEO; GSM844642

DR   GEO; GSM887416

DR   GEO; GSM888495

DR   GEO; GSM1153411

DR   GEO; GSM1181351

DR   GEO; GSM1374728

DR   GEO; GSM1374729

DR   GEO; GSM1374730

DR   GEO; GSM1670227

DR   IGRhCellID; NCIH226

DR   KCLB; 90226

DR   SKY/M-FISH/CGH; 2802

RX   PubMed=2041050;

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=8806101;

RX   PubMed=8956792;

RX   PubMed=9649128;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=10

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 61 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90226; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 13,14

ST   D16S539: 9,12

ST   D18S51: 16

ST   D19S433: 15

ST   D21S11: 29,32.2

ST   D2S1338: 25

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 8,10

ST   D8S1179: 14,15

ST   FGA: 20,23

ST   Penta D: 9,10

ST   Penta E: 12,15

ST   TH01: 8,9.3

ST   TPOX: 8,11 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   TPOX: 8 (PubMed=19372543)

ST   vWA: 17

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H226Br

AC   CVCL_AX73

SY   H226Br; 226Br

DR   BTO; BTO:0000171

RX   PubMed=7634243;

RX   PubMed=8956792;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1544 ! NCI-H226

SX   Male

CA   Cancer cell line

//

ID   NCI-H2279

AC   CVCL_9642

SY   H2279; H-2279

DR   EFO; EFO_0003120

DR   Cosmic; 1028939

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2280

AC   CVCL_S142

SY   H2280; H-2280

DR   ATCC; CRL-5937

DR   BioSample; SAMN03472604

CC   Discontinued: ATCC; CRL-5937; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 11,12

ST   vWA: 15,19

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2282

AC   CVCL_9643

SY   H2282; H-2282

DR   EFO; EFO_0003121

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2284

AC   CVCL_A529

SY   H2284; H-2284

RX   PubMed=8806092;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2286

AC   CVCL_1545

SY   H2286; H-2286; NCIH2286

DR   CLO; CLO_0008069

DR   ATCC; CRL-5938

DR   CCLE; NCIH2286_LUNG

DR   Cosmic; 980992

DR   Cosmic; 1032464

DR   GDSC; 1298355

DR   GEO; GSM434790

DR   GEO; GSM827513

DR   GEO; GSM887417

DR   GEO; GSM888496

DR   GEO; GSM1374731

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 11,12

ST   vWA: 15,19

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2287

AC   CVCL_9644

SY   H2287; H-2287

DR   EFO; EFO_0003122

RX   PubMed=8806092;

DI   NCIt; C4878; Lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2291

AC   CVCL_1546

SY   H2291; H-2291

DR   CLO; CLO_0008070

DR   ATCC; CRL-5939

DR   BioSample; SAMN03472605

DR   CCLE; NCIH2291_LUNG

DR   ChEMBL-Cells; CHEMBL3308880

DR   ChEMBL-Targets; CHEMBL2366197

DR   Cosmic; 724874

DR   Cosmic; 903618

DR   Cosmic; 1995566

DR   Cosmic; 2125247

DR   Cosmic-CLP; 724874

DR   GDSC; 724874

DR   GEO; GSM513960

DR   GEO; GSM514345

DR   GEO; GSM794364

DR   GEO; GSM887418

DR   GEO; GSM888497

DR   GEO; GSM1374732

DR   GEO; GSM1670228

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 9,12

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 14

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H23

AC   CVCL_1547

SY   NCI.H23; H23; H-23; NCIH23

DR   BTO; BTO:0003238

DR   CLO; CLO_0008071

DR   EFO; EFO_0002286

DR   ATCC; CRL-5800

DR   BioSample; SAMN03471316

DR   BioSample; SAMN03471735

DR   CCLE; NCIH23_LUNG

DR   CCRID; 3111C0001CCC000255

DR   ChEMBL-Cells; CHEMBL3307750

DR   ChEMBL-Targets; CHEMBL614997

DR   Cosmic; 687818

DR   Cosmic; 722038

DR   Cosmic; 801587

DR   Cosmic; 844829

DR   Cosmic; 852004

DR   Cosmic; 875849

DR   Cosmic; 876142

DR   Cosmic; 877237

DR   Cosmic; 905942

DR   Cosmic; 910561

DR   Cosmic; 914948

DR   Cosmic; 917993

DR   Cosmic; 953983

DR   Cosmic; 961834

DR   Cosmic; 974292

DR   Cosmic; 1004697

DR   Cosmic; 1089217

DR   Cosmic; 1092619

DR   Cosmic; 1146906

DR   Cosmic; 1154591

DR   Cosmic; 1175864

DR   Cosmic; 1188590

DR   Cosmic; 1219060

DR   Cosmic; 1239881

DR   Cosmic; 1305347

DR   Cosmic; 1312332

DR   Cosmic; 1436010

DR   Cosmic; 1802313

DR   Cosmic; 1870271

DR   Cosmic; 1995567

DR   Cosmic; 1998461

DR   Cosmic; 2125183

DR   Cosmic; 2433751

DR   Cosmic-CLP; 905942

DR   GDSC; 905942

DR   GEO; GSM50214

DR   GEO; GSM50277

DR   GEO; GSM206487

DR   GEO; GSM253310

DR   GEO; GSM353232

DR   GEO; GSM385519

DR   GEO; GSM385530

DR   GEO; GSM434335

DR   GEO; GSM482108

DR   GEO; GSM513961

DR   GEO; GSM514346

DR   GEO; GSM750803

DR   GEO; GSM794267

DR   GEO; GSM799341

DR   GEO; GSM799404

DR   GEO; GSM827478

DR   GEO; GSM847075

DR   GEO; GSM844643

DR   GEO; GSM887421

DR   GEO; GSM888500

DR   GEO; GSM1153412

DR   GEO; GSM1181268

DR   GEO; GSM1181312

DR   GEO; GSM1374733

DR   GEO; GSM1374734

DR   GEO; GSM1374735

DR   GEO; GSM1670229

DR   IGRhCellID; NCIH23

DR   KCLB; 90023

DR   SKY/M-FISH/CGH; 2796

RX   PubMed=2041050;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23381221;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24135919;

RX   PubMed=25120651;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=6

WW   http://www.addexbio.com/productdetail?pid=4861

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-401.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 35 hours (PubMed=25984343); 33.4 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'H23' in PubMed=23381221 and PubMed=25120651 (confirmed by author personal communication).

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11 (ATCC)

ST   D16S539: 9,11 (Cosmic-CLP; PubMed=19372543; PubMed=25877200)

ST   D18S51: 14,16

ST   D19S433: 12,14

ST   D21S11: 30

ST   D2S1338: 18,23

ST   D3S1358: 15

ST   D5S818: 12,13 (ATCC; Cosmic-CLP; KCLB; PubMed=19372543)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 9,10

ST   D8S1179: 15

ST   FGA: 24

ST   Penta D: 8

ST   Penta E: 7,17

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H23-Luc

AC   CVCL_4W97

DR   JCRB; JCRB1509

DR   JCRB; NIHS0727

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 12,13

ST   D7S820: 9,10

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1547 ! NCI-H23

SX   Male

CA   Cancer cell line

//

ID   NCI-H2330

AC   CVCL_1548

SY   H2330; H-2330

DR   CLO; CLO_0008072

DR   ATCC; CRL-5940

DR   BioSample; SAMN03472606

DR   Cosmic; 688019

DR   GEO; GSM827444

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2332

AC   CVCL_A530

SY   H2332; H-2332

DR   Cosmic; 1021883

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2342

AC   CVCL_1549

SY   H2342; H-2342

DR   CLO; CLO_0008073

DR   ATCC; CRL-5941

DR   BioSample; SAMN03472998

DR   CCLE; NCIH2342_LUNG

DR   ChEMBL-Cells; CHEMBL3308773

DR   ChEMBL-Targets; CHEMBL1075537

DR   Cosmic; 687819

DR   Cosmic; 903619

DR   Cosmic; 1609514

DR   Cosmic; 1995568

DR   Cosmic-CLP; 687819

DR   GDSC; 687819

DR   GEO; GSM513962

DR   GEO; GSM514347

DR   GEO; GSM794365

DR   GEO; GSM827408

DR   GEO; GSM887419

DR   GEO; GSM888498

DR   GEO; GSM1374736

DR   GEO; GSM1670230

RX   PubMed=8806092;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 17

ST   D21S11: 31.2,32

ST   D3S1358: 14

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 14,15

ST   FGA: 20

ST   Penta D: 12

ST   Penta E: 5

ST   TH01: 9,9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2347

AC   CVCL_1550

SY   H2347; H-2347; NCIH2347

DR   BTO; BTO:0005293

DR   CLO; CLO_0008074

DR   EFO; EFO_0002287

DR   ATCC; CRL-5942

DR   BioSample; SAMN03472999

DR   CCLE; NCIH2347_LUNG

DR   ChEMBL-Cells; CHEMBL3308386

DR   ChEMBL-Targets; CHEMBL1075538

DR   Cosmic; 687820

DR   Cosmic; 877253

DR   Cosmic; 903620

DR   Cosmic; 914950

DR   Cosmic; 1146907

DR   Cosmic; 1239893

DR   Cosmic; 1925843

DR   Cosmic; 2125248

DR   Cosmic-CLP; 687820

DR   GDSC; 687820

DR   GEO; GSM62332

DR   GEO; GSM253354

DR   GEO; GSM303896

DR   GEO; GSM337707

DR   GEO; GSM434254

DR   GEO; GSM513963

DR   GEO; GSM514348

DR   GEO; GSM784201

DR   GEO; GSM794366

DR   GEO; GSM827514

DR   GEO; GSM844644

DR   GEO; GSM887420

DR   GEO; GSM888499

DR   GEO; GSM1374737

DR   GEO; GSM1670231

DR   IGRhCellID; NCIH2347

RX   PubMed=8806092;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12,14

ST   D16S539: 11

ST   D18S51: 12,19

ST   D21S11: 31,31.2

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 10,13

ST   FGA: 20,25

ST   Penta D: 12

ST   Penta E: 8,19

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2656 ! NCI-BL2347

SX   Female

CA   Cancer cell line

//

ID   NCI-H2365

AC   CVCL_A531

SY   H2365; H-2365

RX   PubMed=8806092;

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2369

AC   CVCL_A532

SY   H2369; H-2369

DR   EFO; EFO_0006678

DR   BioSample; SAMN03471012

DR   Cosmic; 1995411

DR   Cosmic-CLP; 1290808

DR   GDSC; 1290808

DR   GEO; GSM1669818

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 13,15

ST   D21S11: 29

ST   D3S1358: 16

ST   D5S818: 10,12

ST   D7S820: 10

ST   D8S1179: 11,13

ST   FGA: 19,21

ST   Penta D: 14

ST   Penta E: 7,13

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2373

AC   CVCL_A533

SY   H2373; H-2373

DR   EFO; EFO_0006679

DR   ATCC; CRL-5943

DR   BioSample; SAMN03471008

DR   BioSample; SAMN03472607

DR   Cosmic; 886391

DR   Cosmic; 1032375

DR   Cosmic; 1522781

DR   Cosmic; 1541217

DR   Cosmic-CLP; 1290809

DR   GDSC; 1290809

DR   GEO; GSM726265

DR   GEO; GSM1669819

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=21642991;

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Discontinued: ATCC; CRL-5943; true.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,12

ST   D16S539: 12

ST   D18S51: 17

ST   D21S11: 30

ST   D3S1358: 16,18

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   D8S1179: 12,15

ST   FGA: 19,22

ST   Penta D: 12

ST   Penta E: 5,11

ST   TH01: 9.3,10

ST   TPOX: 8

ST   vWA: 14,18 (ATCC)

ST   vWA: 14 (Cosmic-CLP; PubMed=25877200)

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2380

AC   CVCL_A534

SY   H2380; H-2380

DR   ATCC; CRL-5986

DR   BioSample; SAMN03472633

RX   PubMed=8626706;

RX   PubMed=8806092;

CC   Discontinued: ATCC; CRL-5986; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 13,15

ST   D7S820: 9

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 14,17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2405

AC   CVCL_1551

SY   H2405; H-2405; NCIH2405

DR   CLO; CLO_0008075

DR   EFO; EFO_0002288

DR   ATCC; CRL-5944

DR   BioSample; SAMN03470822

DR   CCLE; NCIH2405_LUNG

DR   ChEMBL-Cells; CHEMBL3308774

DR   ChEMBL-Targets; CHEMBL1075539

DR   Cosmic; 687821

DR   Cosmic; 1802309

DR   Cosmic; 1995569

DR   Cosmic-CLP; 687821

DR   GDSC; 687821

DR   GEO; GSM206488

DR   GEO; GSM513964

DR   GEO; GSM514349

DR   GEO; GSM794367

DR   GEO; GSM844645

DR   GEO; GSM887422

DR   GEO; GSM888501

DR   GEO; GSM1670232

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 16

ST   D21S11: 29,30

ST   D3S1358: 11

ST   D5S818: 11,12

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 18,21

ST   Penta D: 9,16

ST   Penta E: 12,14

ST   TH01: 9

ST   TPOX: 8,10

ST   vWA: 16,17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2409

AC   CVCL_A535

SY   H2409; H-2409

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2427

AC   CVCL_Y288

SY   H2427; H-2427

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2444

AC   CVCL_1552

SY   H2444; H-2444

DR   CLO; CLO_0008076

DR   ATCC; CRL-5945

DR   BioSample; SAMN03472608

DR   BioSample; SAMN03473022

DR   CCLE; NCIH2444_LUNG

DR   Cosmic; 1146908

DR   Cosmic; 1995570

DR   Cosmic-CLP; 1298356

DR   GDSC; 1298356

DR   GEO; GSM434295

DR   GEO; GSM887423

DR   GEO; GSM888502

DR   GEO; GSM1374738

DR   GEO; GSM1670233

DR   GEO; GSM1682810

DR   IGRhCellID; H2444GEO

DR   PRIDE; PXD002556

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D18S51: 13

ST   D21S11: 28,29

ST   D3S1358: 14

ST   D5S818: 10

ST   D7S820: 8,10 (ATCC; Cosmic-CLP)

ST   D7S820: 8 (PubMed=25877200)

ST   D8S1179: 11,12,13

ST   FGA: 25

ST   Penta D: 9,12

ST   Penta E: 5

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2452

AC   CVCL_1553

SY   H2452; H-2452; NCIH2452

DR   CLO; CLO_0008077

DR   EFO; EFO_0006680

DR   ATCC; CRL-5946

DR   BioSample; SAMN03471009

DR   CCLE; NCIH2452_PLEURA

DR   CCRID; 3131C0001001200017

DR   ChEMBL-Cells; CHEMBL3308580

DR   ChEMBL-Targets; CHEMBL1075540

DR   Cosmic; 886392

DR   Cosmic; 908462

DR   Cosmic; 1032373

DR   Cosmic; 1481546

DR   Cosmic; 1522763

DR   Cosmic; 1541212

DR   Cosmic; 1571798

DR   Cosmic; 1749557

DR   Cosmic; 1963328

DR   Cosmic; 1995571

DR   Cosmic; 2474096

DR   Cosmic-CLP; 908462

DR   GDSC; 908462

DR   GEO; GSM726266

DR   GEO; GSM827515

DR   GEO; GSM887424

DR   GEO; GSM888503

DR   GEO; GSM1670234

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=21642991;

RX   PubMed=22460905;

RX   PubMed=24926545;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 48 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,13

ST   D18S51: 15

ST   D21S11: 28,32.2

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 10

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 12,15

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2461

AC   CVCL_A536

SY   H2461; H-2461

DR   EFO; EFO_0006681

DR   BioSample; SAMN03471038

DR   Cosmic; 1032371

DR   Cosmic; 1087353

DR   Cosmic-CLP; 1290810

DR   GDSC; 1290810

DR   GEO; GSM1669820

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 9,12

ST   D16S539: 9,11

ST   D18S51: 15

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 11,12

ST   FGA: 20,22

ST   Penta D: 12

ST   Penta E: 10,11

ST   TH01: 6,9

ST   TPOX: 8,10

ST   vWA: 15,17 (Cosmic-CLP)

ST   vWA: 17 (PubMed=25877200)

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H249

AC   CVCL_A537

SY   H249; H-249; NCIH249

DR   ATCC; CRL-5827

DR   BioSample; SAMN03151645

DR   BioSample; SAMN03151860

DR   BioSample; SAMN03471746

DR   Cosmic; 755460

DR   Cosmic; 877204

DR   Cosmic; 980931

DR   Cosmic; 1006529

DR   Cosmic; 1021857

DR   Cosmic; 1032397

DR   Cosmic; 2125249

DR   GEO; GSM845545

DR   GEO; GSM844646

DR   KCLB; 90249

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=20143388;

WW   http://www.atcc.org/support/faqs/4bf60/NCIH249%20ATCC%20CRL5827-1073.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-H69 derivative (PubMed=20143388).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5827; true.

CC   Discontinued: KCLB; 90249; probable.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H250

AC   CVCL_1554

SY   H250; H-250

DR   CLO; CLO_0008078

DR   ATCC; CRL-5828

DR   BioSample; SAMN03471747

DR   ChEMBL-Cells; CHEMBL3308294

DR   ChEMBL-Targets; CHEMBL2366289

DR   Cosmic; 688020

DR   Cosmic; 924241

DR   Cosmic; 1021858

DR   Cosmic-CLP; 924241

DR   GDSC; 924241

DR   GEO; GSM1670235

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=27397505;

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Brain.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 9,13

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2509

AC   CVCL_A538

SY   H2509; H-2509

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2527

AC   CVCL_A539

SY   H2527; H-2527

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2540

AC   CVCL_A540

SY   H2540; H-2540

RX   PubMed=8806092;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2552

AC   CVCL_A541

SY   H2552; H-2552

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2562

AC   CVCL_X977

SY   H2562; H-2562

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2580

AC   CVCL_A542

SY   H2580; H-2580

RX   PubMed=8806092;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2591

AC   CVCL_A543

SY   H2591; H-2591

DR   BioSample; SAMN03471042

DR   Cosmic; 1032379

DR   Cosmic-CLP; 1240131

DR   GDSC; 1240131

DR   GEO; GSM1669821

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,14

ST   D13S317: 12

ST   D16S539: 10,12

ST   D18S51: 12

ST   D21S11: 30,32.2

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   D8S1179: 8,14

ST   FGA: 19,22

ST   Penta D: 12

ST   Penta E: 5,10

ST   TH01: 8

ST   TPOX: 8,12

ST   vWA: 16,17

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2594

AC   CVCL_A544

SY   H2594; H-2594

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2595

AC   CVCL_A545

SY   H2595; H-2595

DR   EFO; EFO_0006682

DR   BioSample; SAMN03471011

DR   Cosmic; 1032381

DR   Cosmic; 1087354

DR   Cosmic-CLP; 1240132

DR   GDSC; 1240132

DR   GEO; GSM1669822

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 12,24

ST   D21S11: 29,31.2

ST   D3S1358: 18

ST   D5S818: 13

ST   D7S820: 7,9

ST   D8S1179: 10,14

ST   FGA: 23,25

ST   Penta D: 13,14

ST   Penta E: 11,13

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 15,16

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2596

AC   CVCL_A546

SY   H2596; H-2596

DR   EFO; EFO_0006683

DR   BioSample; SAMN03471021

DR   Cosmic; 1032390

DR   Cosmic; 1087355

DR   GDSC; 1240133

RX   PubMed=7695406;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 12

ST   D18S51: 14

ST   D21S11: 29,33.2

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 13,16

ST   FGA: 20

ST   Penta D: 12,13

ST   Penta E: 12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 15,16

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2597

AC   CVCL_A547

SY   H2597; H-2597

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2600

AC   CVCL_A548

SY   H2600; H-2600

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2618

AC   CVCL_A549

SY   H2618; H-2618

DR   Cosmic; 1032391

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2679

AC   CVCL_A550

SY   H2679; H-2679

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2691

AC   CVCL_A551

SY   H2691; H-2691

DR   BioSample; SAMN03471020

DR   Cosmic; 1087356

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 21

ST   D21S11: 30,31

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 10,13

ST   Penta E: 8,9

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2706

AC   CVCL_A552

SY   H2706; H-2706

RX   PubMed=8806092;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2712

AC   CVCL_Y289

SY   H2712; H-2712

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2722

AC   CVCL_U994

SY   H2722; H-2722

DR   EFO; EFO_0006684

DR   BioSample; SAMN03471016

DR   Cosmic; 1995413

DR   Cosmic-CLP; 1290812

DR   GDSC; 1290812

DR   GEO; GSM1669823

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y (Cosmic-CLP)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 10,11

ST   D13S317: 11 (Cosmic-CLP)

ST   D13S317: 7.2,11 (PubMed=25877200)

ST   D16S539: 13

ST   D18S51: 11,13

ST   D21S11: 29,33.2

ST   D3S1358: 17

ST   D5S818: 9,11

ST   D7S820: 10,11

ST   D8S1179: 11,15

ST   FGA: 23

ST   Penta D: 10,13

ST   Penta E: 5,19

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2731

AC   CVCL_U995

SY   H2731; H-2731

DR   BioSample; SAMN03471019

DR   Cosmic-CLP; 1240134

DR   GDSC; 1240134

DR   GEO; GSM1669824

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,13 (Cosmic-CLP)

ST   D13S317: 11 (PubMed=25877200)

ST   D16S539: 13

ST   D18S51: 15

ST   D21S11: 30,31.2

ST   D3S1358: 17

ST   D5S818: 11,12

ST   D7S820: 8,14

ST   D8S1179: 8,12

ST   FGA: 21

ST   Penta D: 11,12

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C45655; Sarcomatoid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2795

AC   CVCL_U996

SY   H2795; H-2795

DR   EFO; EFO_0006685

DR   BioSample; SAMN03471022

DR   Cosmic; 1995414

DR   Cosmic-CLP; 1290813

DR   GDSC; 1290813

DR   GEO; GSM1669825

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 11,13

ST   D16S539: 11

ST   D18S51: 11,16

ST   D19S433: 15

ST   D21S11: 29,30

ST   D2S1338: 18,25

ST   D3S1358: 14,15

ST   D5S818: 9,11

ST   D7S820: 10,12

ST   D8S1179: 12,13

ST   FGA: 23

ST   Penta D: 9,13

ST   Penta E: 7,13

ST   TH01: 6

ST   TPOX: 9,11

ST   vWA: 17,19

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H28

AC   CVCL_1555

SY   H28; H-28; HUT-28; HUT 28; HuT 28; HUT28; Hut28; HuT28

DR   CLO; CLO_0008079

DR   EFO; EFO_0006686

DR   ATCC; CRL-5820

DR   BioSample; SAMN03471010

DR   CCLE; NCIH28_PLEURA

DR   ChEMBL-Cells; CHEMBL3308775

DR   ChEMBL-Targets; CHEMBL1075541

DR   Cosmic; 688059

DR   Cosmic; 733814

DR   Cosmic; 877108

DR   Cosmic; 877350

DR   Cosmic; 886387

DR   Cosmic; 908470

DR   Cosmic; 980995

DR   Cosmic; 1032386

DR   Cosmic; 1146909

DR   Cosmic; 1152495

DR   Cosmic; 1481543

DR   Cosmic; 1522766

DR   Cosmic; 1541208

DR   Cosmic; 1749556

DR   Cosmic; 1963325

DR   Cosmic; 1995572

DR   Cosmic; 2474149

DR   Cosmic-CLP; 908470

DR   GDSC; 908470

DR   GEO; GSM434272

DR   GEO; GSM726267

DR   GEO; GSM794268

DR   GEO; GSM887425

DR   GEO; GSM888504

DR   GEO; GSM1670236

DR   IGRhCellID; H28GEO

DR   KCLB; 90028

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=21642991;

RX   PubMed=22460905;

RX   PubMed=23830731;

RX   PubMed=24926545;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90028; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 12,13

ST   D18S51: 19

ST   D21S11: 29,30

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,12

ST   D8S1179: 10,12

ST   FGA: 19.2,21

ST   Penta D: 9,10

ST   Penta E: 10,16

ST   TH01: 7,9

ST   TPOX: 11

ST   vWA: 14,15

DI   NCIt; C9351; Pleural mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2803

AC   CVCL_U997

SY   H2803; H-2803

DR   EFO; EFO_0006687

DR   BioSample; SAMN03471013

DR   Cosmic; 1995415

DR   Cosmic-CLP; 1240135

DR   GDSC; 1240135

DR   GEO; GSM1669826

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,13

ST   D13S317: 12,13

ST   D16S539: 9,12

ST   D18S51: 21

ST   D21S11: 30,31

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 8,11

ST   D8S1179: 13

ST   FGA: 22

ST   Penta D: 10,13

ST   Penta E: 8,9

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2804

AC   CVCL_U998

SY   H2804; H-2804

DR   EFO; EFO_0006688

DR   BioSample; SAMN03471014

DR   Cosmic; 1995416

DR   Cosmic-CLP; 1240136

DR   GDSC; 1240136

DR   GEO; GSM1669827

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 10

ST   D16S539: 9,11

ST   D18S51: 18

ST   D21S11: 28,30

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 9

ST   D8S1179: 13,15

ST   FGA: 23

ST   Penta D: 13

ST   Penta E: 7,10

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 14,15

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2810

AC   CVCL_U999

SY   H2810; H-2810

DR   EFO; EFO_0006689

DR   BioSample; SAMN03471017

DR   Cosmic-CLP; 1240137

DR   GDSC; 1240137

DR   GEO; GSM1669828

RX   PubMed=23830731;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 10,11

ST   D18S51: 12

ST   D21S11: 29

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 7,12

ST   D8S1179: 13

ST   FGA: 20,21.2

ST   Penta D: 14

ST   Penta E: 8,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2818

AC   CVCL_V000

SY   H2818; H-2818

DR   Cosmic; 1995417

DR   Cosmic-CLP; 1290814

DR   GDSC; 1290814

DR   GEO; GSM1669829

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11,12

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C7985; Epithelioid mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H285

AC   CVCL_A553

SY   H285; H-285

DR   ATCC; CRL-5829

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Discontinued: ATCC; CRL-5829; true.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2850

AC   CVCL_Y290

SY   H2850; H-2850

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H2869

AC   CVCL_V001

SY   H2869; H-2869

DR   Cosmic; 1995418

DR   Cosmic-CLP; 1240138

DR   GDSC; 1240138

DR   GEO; GSM1669830

RX   PubMed=23830731;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,11

ST   D16S539: 13

ST   D5S818: 12,13

ST   D7S820: 7,8

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C4282; Biphasic mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H2882

AC   CVCL_5158

SY   H2882; H-2882

DR   Cosmic; 755471

DR   Cosmic; 903621

DR   Cosmic; 1146910

DR   GEO; GSM253402

DR   GEO; GSM434255

DR   GEO; GSM794368

DR   IGRhCellID; H2882GEO

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S844 ! NCI-BL2882

SX   Female

CA   Cancer cell line

//

ID   NCI-H2887

AC   CVCL_5159

SY   H2887; H-2887

DR   Cosmic; 903622

DR   Cosmic; 1146911

DR   GEO; GSM253355

DR   GEO; GSM434256

DR   GEO; GSM794369

DR   IGRhCellID; H2887GEO

RX   PubMed=10987304;

RX   PubMed=11314036;

RX   PubMed=12759538;

RX   PubMed=20679594;

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11

ST   D5S818: 10,11

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 12

ST   vWA: 17

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_S845 ! NCI-BL2887

SX   Male

CA   Cancer cell line

//

ID   NCI-H289

AC   CVCL_A554

SY   H289: H-289

DR   Cosmic; 877205

DR   Cosmic; 1021859

DR   Cosmic; 1320183

DR   GEO; GSM794279

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10987304;

RX   PubMed=11030152;

RX   PubMed=11314036;

RX   PubMed=20679594;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 13

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 8,11

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 17,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E095 ! NCI-BL289

SX   Female

CA   Cancer cell line

//

ID   NCI-H290

AC   CVCL_A555

SY   H290: H-290; HUT-290; Hut-290; HUT 290; HUT290

DR   BioSample; SAMN03471037

DR   Cosmic; 733817

DR   Cosmic; 877270

DR   Cosmic; 877403

DR   Cosmic; 886389

DR   Cosmic; 980996

DR   Cosmic; 1032387

DR   Cosmic; 1152498

DR   Cosmic; 1995419

DR   Cosmic-CLP; 1240139

DR   GDSC; 1240139

DR   GEO; GSM794280

DR   GEO; GSM1669831

DR   KCLB; 90290

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=20679594;

RX   PubMed=23830731;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90290; probable.

ST   Source(s): Cosmic-CLP; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,12

ST   D18S51: 14,15

ST   D19S433: 13,15

ST   D21S11: 28,31.2

ST   D2S1338: 17,19

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 10,14

ST   FGA: 21,22

ST   Penta D: 11,12

ST   Penta E: 7,11

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H292

AC   CVCL_0455

SY   H292; H-292; NCI-HUT-292; Hut292; NCIH292

DR   BTO; BTO:0002418

DR   CLO; CLO_0008080

DR   EFO; EFO_0006690

DR   MCCL; MCC:0000353

DR   CLDB; cl3653

DR   CLDB; cl3654

DR   ATCC; CRL-1848

DR   BCRC; 60372

DR   BCRJ; 0187

DR   BioSample; SAMN03471312

DR   CCLE; NCIH292_LUNG

DR   CCRID; 3111C0001CCC000233

DR   CCRID; 3131C0001000700122

DR   ChEMBL-Cells; CHEMBL3308637

DR   ChEMBL-Targets; CHEMBL614733

DR   Cosmic; 753604

DR   Cosmic; 844598

DR   Cosmic; 877404

DR   Cosmic; 1017828

DR   Cosmic; 1047099

DR   Cosmic; 1152499

DR   Cosmic; 1188584

DR   Cosmic; 1288262

DR   Cosmic; 1466803

DR   Cosmic; 1519249

DR   Cosmic; 1520933

DR   Cosmic; 1520947

DR   Cosmic; 1870272

DR   Cosmic; 1995573

DR   Cosmic-CLP; 753604

DR   ECACC; 91091815

DR   GDSC; 753604

DR   GEO; GSM206489

DR   GEO; GSM784237

DR   GEO; GSM794281

DR   GEO; GSM888505

DR   GEO; GSM1670237

DR   ICLC; HTL96009

DR   KCB; KCB 200822YJ

DR   KCLB; 21848

DR   SKY/M-FISH/CGH; 2844

RX   PubMed=8806092;

RX   PubMed=15193437;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 21848; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11,12

ST   D16S539: 9,13

ST   D18S51: 16

ST   D21S11: 28

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 10

ST   D8S1179: 11,14

ST   FGA: 22,26

ST   Penta D: 9

ST   Penta E: 13,15

ST   TH01: 8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C45544; Lung mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H2925

AC   CVCL_Y291

SY   H2925; H-2925

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H295

AC   CVCL_0456

SY   H295; H-295; NCI-H-295

DR   BTO; BTO:0002587

DR   CLO; CLO_0008081

DR   MCCL; MCC:0000502

DR   ATCC; CRL-10296

DR   BCRC; 60354

DR   BioSample; SAMN03471298

DR   Cosmic; 684682

DR   Cosmic; 908466

DR   Cosmic; 1179076

DR   Cosmic; 2239455

DR   Cosmic; 2364100

DR   TOKU-E; 2687

DR   Wikidata; Q28226675

RX   PubMed=2386954;

RX   PubMed=8056157;

RX   PubMed=8404594;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=15541570;

RX   PubMed=21924324;

RX   PubMed=22266826;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-402.html

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H295A

AC   CVCL_0457

SY   H295A; H-295A

DR   BTO; BTO:0005669

DR   MCCL; MCC:0000354

RX   PubMed=9024219;

RX   PubMed=15541570;

RX   PubMed=18000308;

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R

AC   CVCL_0458

SY   H295R; H-295R; H295R-S1

DR   BTO; BTO:0002588

DR   CLO; CLO_0008082

DR   EFO; EFO_0002289

DR   MCCL; MCC:0000355

DR   ATCC; CRL-2128

DR   CCRID; 3111C0001CCC000256

DR   ChEMBL-Cells; CHEMBL3307998

DR   ChEMBL-Targets; CHEMBL612593

DR   CLS; 300483/p789_NCI-H295R

DR   Cosmic; 1172633

DR   Cosmic; 1191070

DR   Cosmic; 1622873

DR   Cosmic; 2364101

DR   Cosmic; 2574494

DR   IGRhCellID; NCIH295R

DR   Wikidata; Q25323725

RX   PubMed=15541570;

RX   PubMed=18000308;

RX   PubMed=21924324;

RX   PubMed=22266826;

RX   PubMed=23951072;

WW   https://en.wikipedia.org/wiki/H295R

ST   Source(s): ATCC; CLS

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 17

ST   D21S11: 32.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 13

ST   FGA: 19.2,24

ST   Penta D: 8

ST   Penta E: 5,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R-S2

AC   CVCL_S901

SY   H295R-S2

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H295R-S3

AC   CVCL_S902

SY   H295R-S3

RX   PubMed=21924324;

RX   PubMed=22266826;

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0456 ! NCI-H295

SX   Female

CA   Cancer cell line

//

ID   NCI-H2973

AC   CVCL_E105

SY   H2973; H-2973

RX   PubMed=11030152;

RX   PubMed=12759538;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H298

AC   CVCL_A556

SY   H298; H-298

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H3026

AC   CVCL_Y292

SY   H3026; H-3026

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3030

AC   CVCL_Y293

SY   H3030; H-3030

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3072

AC   CVCL_Y294

SY   H3072; H-3072

RX   PubMed=11030152;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3118

AC   CVCL_A464

SY   H3118; H-3118

DR   Cosmic; 1288269

DR   Cosmic; 1519250

DR   Cosmic-CLP; 1240140

DR   GDSC; 1240140

DR   GEO; GSM1669832

DR   SKY/M-FISH/CGH; 2845

RX   PubMed=11030152;

RX   PubMed=15193437;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12,14

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 8,12

ST   vWA: 17

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H3122

AC   CVCL_5160

SY   H3122; H-3122; NCIH3122

DR   Cosmic; 755472

DR   Cosmic; 914951

DR   Cosmic; 1146912

DR   Cosmic; 2245571

DR   Cosmic-CLP; 1240190

DR   GDSC; 1240190

DR   GEO; GSM253349

DR   GEO; GSM434307

DR   GEO; GSM794370

DR   GEO; GSM1374739

DR   GEO; GSM1374740

DR   GEO; GSM1670238

DR   IGRhCellID; H3122GEO

DR   PRIDE; PXD002556

RX   PubMed=11030152;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=24675041;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; PubMed=20679594;

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 7,9.3

ST   TPOX: 10

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3123

AC   CVCL_Y295

SY   H3123; H-3123

RX   PubMed=11030152;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3166

AC   CVCL_X979

SY   H3166; H-3166

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H3211

AC   CVCL_X978

SY   H3211; H-3211

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H322

AC   CVCL_1556

SY   H322; H-322; H322T; NCI-H322T; NCI-322

DR   BTO; BTO:0003007

DR   CLO; CLO_0008083

DR   EFO; EFO_0006691

DR   CLDB; cl3655

DR   ATCC; CRL-5806

DR   BioSample; SAMN03471699

DR   BioSample; SAMN03471740

DR   BioSample; SAMN03473287

DR   CCLE; NCIH322_LUNG

DR   ChEMBL-Cells; CHEMBL3307405

DR   ChEMBL-Targets; CHEMBL614573

DR   Cosmic; 687822

DR   Cosmic; 801589

DR   Cosmic; 844830

DR   Cosmic; 876143

DR   Cosmic; 903571

DR   Cosmic; 917976

DR   Cosmic; 929972

DR   Cosmic; 932922

DR   Cosmic; 934547

DR   Cosmic; 980962

DR   Cosmic; 1028935

DR   Cosmic; 1032434

DR   Cosmic; 1146913

DR   Cosmic; 1152500

DR   Cosmic; 1239903

DR   Cosmic; 1802317

DR   Cosmic; 1870261

DR   Cosmic; 1891884

DR   Cosmic; 2042867

DR   Cosmic; 2125250

DR   ECACC; 95111734

DR   GEO; GSM206490

DR   GEO; GSM253358

DR   GEO; GSM434333

DR   GEO; GSM784245

DR   GEO; GSM794282

DR   GEO; GSM827434

DR   GEO; GSM887426

DR   GEO; GSM888506

DR   GEO; GSM1374741

DR   IGRhCellID; NCIH322

DR   KCLB; 90322

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=20679594;

RX   PubMed=22460905;

RX   PubMed=25485619;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.

CC   Discontinued: ATCC; CRL-5806; true.

CC   Discontinued: KCLB; 90322; probable.

ST   Source(s): ATCC; ECACC; PubMed=11416159; PubMed=20679594; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; ECACC; PubMed=11416159; PubMed=20679594)

ST   Amelogenin: X (PubMed=25877200)

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 17

ST   D21S11: 28

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 7

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H322M

AC   CVCL_1557

SY   NCI.H322M; H322M; H-322M

DR   BTO; BTO:0004182

DR   ChEMBL-Cells; CHEMBL3307710

DR   ChEMBL-Targets; CHEMBL614803

DR   Cosmic; 875851

DR   Cosmic; 905967

DR   Cosmic; 974293

DR   Cosmic; 1092620

DR   Cosmic; 1175865

DR   Cosmic; 1305348

DR   Cosmic; 1312333

DR   Cosmic; 1995574

DR   Cosmic; 1998462

DR   Cosmic-CLP; 905967

DR   GDSC; 905967

DR   GEO; GSM50215

DR   GEO; GSM50278

DR   GEO; GSM434296

DR   GEO; GSM750802

DR   GEO; GSM799342

DR   GEO; GSM799405

DR   GEO; GSM1153413

DR   GEO; GSM1181269

DR   GEO; GSM1181316

DR   GEO; GSM1374742

DR   GEO; GSM1670239

DR   IGRhCellID; H322M_03GEO

DR   SKY/M-FISH/CGH; 2797

RX   PubMed=2041050;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=11

WW   http://tcpaportal.org/mclp/

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 35.3 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

CC   Caution: We are not certain that NCI-H322 and NCI-H322M are identical.

ST   Source(s): Cosmic-CLP; PubMed=19372543

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 17

ST   D19S433: 14

ST   D21S11: 28

ST   D2S1338: 19,25

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 11

ST   D8S1179: 12,15

ST   FGA: 22

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1556 ! NCI-H322

SX   Male

CA   Cancer cell line

//

ID   NCI-H324

AC   CVCL_3953

SY   H324; H-324

DR   BTO; BTO:0003005

DR   Cosmic; 844594

DR   Cosmic; 877238

DR   Cosmic; 877406

DR   Cosmic; 903572

DR   Cosmic; 1152501

DR   Cosmic; 1891885

DR   GEO; GSM794283

RX   PubMed=8806092;

RX   PubMed=20679594;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=20679594

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H3255

AC   CVCL_6831

SY   H3255; H-3255; H3255_DA

DR   EFO; EFO_0003123

DR   ATCC; CRL-2882

DR   BioSample; SAMN03471808

DR   CCLE; NCIH3255_LUNG

DR   Cosmic; 897734

DR   Cosmic; 903623

DR   Cosmic; 914952

DR   Cosmic; 1028937

DR   Cosmic; 1128245

DR   Cosmic; 1146914

DR   Cosmic-CLP; 1247873

DR   GDSC; 1247873

DR   GEO; GSM63349

DR   GEO; GSM253411

DR   GEO; GSM434297

DR   GEO; GSM794371

DR   GEO; GSM827356

DR   GEO; GSM1374743

DR   GEO; GSM1669833

DR   IGRhCellID; H3255_DAGEO

DR   PRIDE; PXD002224

DR   PRIDE; PXD002556

RX   PubMed=11030152;

RX   PubMed=12759538;

RX   PubMed=20679594;

RX   PubMed=26202522;

RX   PubMed=26361996;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep membrane proteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-2882; true.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=20679594;

ST   Amelogenin: X

ST   CSF1PO: 11,14

ST   D13S317: 11,13

ST   D16S539: 8

ST   D5S818: 11,12

ST   D7S820: 10,13

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H3255DR

AC   CVCL_DI56

SY   H3255DR

RX   PubMed=20118985;

CC   Selected for resistance to: ChEBI; CHEBI:132268; Dacomitinib (PF-00299804).

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DI55 ! NCI-H3255GR

SX   Female

CA   Cancer cell line

//

ID   NCI-H3255GR

AC   CVCL_DI55

SY   H3255GR; H3255 GR

DR   Cosmic; 1128246

RX   PubMed=16906227;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6831 ! NCI-H3255

SX   Female

CA   Cancer cell line

//

ID   NCI-H3282

AC   CVCL_X980

SY   H3282; H-3282

RX   PubMed=11030152;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   NCI-H345

AC   CVCL_1558

SY   H345; H-345; NCI H345; NCIH345

DR   BTO; BTO:0003019

DR   CLO; CLO_0008084

DR   EFO; EFO_0006692

DR   ATCC; HTB-180

DR   BioSample; SAMN03471018

DR   BioSample; SAMN03472734

DR   ChEMBL-Cells; CHEMBL3307324

DR   ChEMBL-Targets; CHEMBL614195

DR   Cosmic; 688021

DR   Cosmic; 755464

DR   Cosmic; 844551

DR   Cosmic; 850440

DR   Cosmic; 877206

DR   Cosmic; 877355

DR   Cosmic; 1006525

DR   Cosmic; 1021860

DR   Cosmic; 1152465

DR   Cosmic; 1219101

DR   Cosmic; 1239938

DR   Cosmic; 2125251

DR   Cosmic-CLP; 688021

DR   GDSC; 688021

DR   GEO; GSM169441

DR   GEO; GSM380512

DR   GEO; GSM784200

DR   GEO; GSM794284

DR   GEO; GSM844647

DR   GEO; GSM1670240

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 8

ST   D18S51: 12,13

ST   D21S11: 29,31

ST   D3S1358: 18

ST   D5S818: 11,12 (ATCC; Cosmic-CLP)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 9,13

ST   D8S1179: 14,16

ST   FGA: 20

ST   Penta D: 12,13

ST   Penta E: 14

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H358

AC   CVCL_1559

SY   H358; H-358; NCIH358

DR   BTO; BTO:0002835

DR   CLO; CLO_0008085

DR   EFO; EFO_0002291

DR   CLDB; cl3656

DR   ATCC; CRL-5807

DR   BioSample; SAMN03471313

DR   CCLE; NCIH358_LUNG

DR   CCRID; 3131C0001000700151

DR   ChEMBL-Cells; CHEMBL3307543

DR   ChEMBL-Targets; CHEMBL614135

DR   Cosmic; 722039

DR   Cosmic; 724875

DR   Cosmic; 877106

DR   Cosmic; 903573

DR   Cosmic; 908465

DR   Cosmic; 910563

DR   Cosmic; 914944

DR   Cosmic; 929970

DR   Cosmic; 934545

DR   Cosmic; 980963

DR   Cosmic; 1004699

DR   Cosmic; 1028934

DR   Cosmic; 1032435

DR   Cosmic; 1052333

DR   Cosmic; 1146915

DR   Cosmic; 1219075

DR   Cosmic; 1239902

DR   Cosmic; 1600603

DR   Cosmic; 1741780

DR   Cosmic; 1802307

DR   Cosmic; 1870273

DR   Cosmic; 1995575

DR   Cosmic; 2042868

DR   Cosmic-CLP; 908465

DR   ECACC; 95111733

DR   GDSC; 908465

DR   GEO; GSM206491

DR   GEO; GSM253398

DR   GEO; GSM385520

DR   GEO; GSM385531

DR   GEO; GSM434257

DR   GEO; GSM513937

DR   GEO; GSM514321

DR   GEO; GSM784251

DR   GEO; GSM794285

DR   GEO; GSM827468

DR   GEO; GSM844648

DR   GEO; GSM887427

DR   GEO; GSM888507

DR   GEO; GSM1374744

DR   GEO; GSM1670241

DR   IGRhCellID; NCIH358

DR   KCLB; 25807

DR   KCLB; 90358

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=8806101;

RX   PubMed=9649128;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-368.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 38 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 12,13

ST   D18S51: 14

ST   D21S11: 28,30

ST   D3S1358: 14,18

ST   D5S818: 10,12

ST   D7S820: 10,11

ST   D8S1179: 13,14

ST   FGA: 20,21

ST   Penta D: 10,13

ST   Penta E: 18

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H360

AC   CVCL_A557

SY   H360; H-360

DR   Cosmic; 1152466

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H369

AC   CVCL_A558

SY   H369; H-369

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H372

AC   CVCL_A559

SY   H372; H-372

DR   Cosmic; 844552

DR   Cosmic; 1152467

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H378

AC   CVCL_1560

SY   H378; H-378; NCIH378

DR   CLO; CLO_0008086

DR   ATCC; CRL-5808

DR   BioSample; SAMN03471741

DR   ChEMBL-Cells; CHEMBL3308295

DR   ChEMBL-Targets; CHEMBL2366088

DR   Cosmic; 688022

DR   Cosmic; 850428

DR   Cosmic; 877207

DR   Cosmic; 877356

DR   Cosmic; 980932

DR   Cosmic; 1021861

DR   Cosmic; 1032398

DR   Cosmic; 1152468

DR   Cosmic; 1995576

DR   Cosmic-CLP; 688022

DR   GDSC; 688022

DR   GEO; GSM794286

DR   GEO; GSM845546

DR   GEO; GSM844649

DR   GEO; GSM1670242

DR   IGRhCellID; NCIH378

DR   KCLB; 90378

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 16,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A560 ! NCI-H379

SX   Female

CA   Cancer cell line

//

ID   NCI-H379

AC   CVCL_A560

SY   H379; H-379

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1560 ! NCI-H378

SX   Female

CA   Cancer cell line

//

ID   NCI-H432

AC   CVCL_A563

SY   H432; H-432

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A564 ! NCI-H433

SX   Male

CA   Cancer cell line

//

ID   NCI-H433

AC   CVCL_A564

SY   H433; H-433

DR   Cosmic; 1152469

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A563 ! NCI-H432

SX   Male

CA   Cancer cell line

//

ID   NCI-H441

AC   CVCL_1561

SY   H441; H-441; NCI-H441-4; NCI-441; NCIH441

DR   BTO; BTO:0001910

DR   CLO; CLO_0008087

DR   EFO; EFO_0002292

DR   ATCC; HTB-174

DR   ATCC; CRM-HTB-174

DR   BCRC; 60455

DR   BCRJ; 0359

DR   BioSample; SAMN03473121

DR   CCLE; NCIH441_LUNG

DR   ChEMBL-Cells; CHEMBL3308121

DR   ChEMBL-Targets; CHEMBL1075542

DR   Cosmic; 687824

DR   Cosmic; 722048

DR   Cosmic; 801590

DR   Cosmic; 844831

DR   Cosmic; 876144

DR   Cosmic; 897730

DR   Cosmic; 903574

DR   Cosmic; 908460

DR   Cosmic; 914949

DR   Cosmic; 917992

DR   Cosmic; 1006533

DR   Cosmic; 1028948

DR   Cosmic; 1052332

DR   Cosmic; 1146916

DR   Cosmic; 1219076

DR   Cosmic; 1239882

DR   Cosmic; 1802306

DR   Cosmic; 1870274

DR   Cosmic; 1945871

DR   Cosmic; 1995577

DR   Cosmic; 2042863

DR   Cosmic; 2125252

DR   Cosmic-CLP; 908460

DR   GDSC; 908460

DR   GEO; GSM206492

DR   GEO; GSM253415

DR   GEO; GSM353231

DR   GEO; GSM385521

DR   GEO; GSM385532

DR   GEO; GSM434308

DR   GEO; GSM784265

DR   GEO; GSM794287

DR   GEO; GSM827516

DR   GEO; GSM844650

DR   GEO; GSM887428

DR   GEO; GSM888508

DR   GEO; GSM1670243

DR   IGRhCellID; NCIH441

DR   IZSLER; BS TCL 215

DR   PRIDE; PXD002556

RX   PubMed=2386953;

RX   PubMed=8806092;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/h/cell-lines-detail-294.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).

CC   Doubling time: 80 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 9,13

ST   D18S51: 18,19

ST   D21S11: 32.2

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 8,14

ST   FGA: 24,25

ST   Penta D: 10,12

ST   Penta E: 12

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C5650; Papillary lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H441/CMV-Luc

AC   CVCL_M254

DR   JCRB; JCRB1497

DR   JCRB; NIHS0728

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0728; true.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 9

ST   D16S539: 9,13

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 17,18

DI   NCIt; C5650; Papillary lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1561 ! NCI-H441

SX   Male

CA   Cancer cell line

//

ID   NCI-H446

AC   CVCL_1562

SY   H446; H-446; NCI-446; NCIH446

DR   CLO; CLO_0008088

DR   EFO; EFO_0002293

DR   ATCC; HTB-171

DR   BioSample; SAMN03473283

DR   CCLE; NCIH446_LUNG

DR   CCRID; 3111C0001CCC000082

DR   CCRID; 3131C0001000700038

DR   ChEMBL-Cells; CHEMBL3307760

DR   ChEMBL-Targets; CHEMBL612440

DR   Cosmic; 688023

DR   Cosmic; 755465

DR   Cosmic; 801352

DR   Cosmic; 844554

DR   Cosmic; 877357

DR   Cosmic; 897516

DR   Cosmic; 929976

DR   Cosmic; 932947

DR   Cosmic; 1006526

DR   Cosmic; 1021863

DR   Cosmic; 1152471

DR   Cosmic; 1219102

DR   Cosmic; 1239939

DR   Cosmic; 1434963

DR   Cosmic; 1995578

DR   Cosmic; 2125198

DR   Cosmic-CLP; 688023

DR   GDSC; 688023

DR   GEO; GSM169448

DR   GEO; GSM380477

DR   GEO; GSM784254

DR   GEO; GSM845547

DR   GEO; GSM887429

DR   GEO; GSM888509

DR   GEO; GSM1670244

DR   GEO; GSM1682798

DR   IGRhCellID; NCIH446

DR   KCB; KCB 200688YJ

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 13,14

ST   D13S317: 8

ST   D16S539: 12

ST   D18S51: 12,13

ST   D21S11: 28

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 13,15

ST   FGA: 22

ST   Penta D: 12,13

ST   Penta E: 9,10

ST   TH01: 8,9.3

ST   TPOX: 9,11

ST   vWA: 18,19

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H449

AC   CVCL_A565

SY   H449; H-449

DR   Cosmic; 1021864

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A566 ! NCI-H450

SX   Female

CA   Cancer cell line

//

ID   NCI-H450

AC   CVCL_A566

SY   H450; H-450

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A565 ! NCI-H449

SX   Female

CA   Cancer cell line

//

ID   NCI-H460

AC   CVCL_0459

SY   NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460

DR   BTO; BTO:0002207

DR   CLO; CLO_0003601

DR   CLO; CLO_0008089

DR   EFO; EFO_0003044

DR   MCCL; MCC:0000356

DR   CLDB; cl1548

DR   ATCC; HTB-177

DR   BCRC; 60373

DR   BioSample; SAMN03471184

DR   CCLE; NCIH460_LUNG

DR   CCLV; CCLV-RIE 0962

DR   CCRID; 3111C0001CCC000355

DR   CCRID; 3131C0001000700039

DR   CGH-DB; 199-1

DR   CGH-DB; 9186-4

DR   ChEMBL-Cells; CHEMBL3307677

DR   ChEMBL-Targets; CHEMBL396

DR   Cosmic; 722064

DR   Cosmic; 724876

DR   Cosmic; 755469

DR   Cosmic; 844595

DR   Cosmic; 875852

DR   Cosmic; 877263

DR   Cosmic; 877407

DR   Cosmic; 897508

DR   Cosmic; 905943

DR   Cosmic; 911996

DR   Cosmic; 931371

DR   Cosmic; 947356

DR   Cosmic; 980964

DR   Cosmic; 1006534

DR   Cosmic; 1017826

DR   Cosmic; 1028956

DR   Cosmic; 1032436

DR   Cosmic; 1044245

DR   Cosmic; 1047102

DR   Cosmic; 1089231

DR   Cosmic; 1092621

DR   Cosmic; 1146917

DR   Cosmic; 1154605

DR   Cosmic; 1152502

DR   Cosmic; 1188592

DR   Cosmic; 1219077

DR   Cosmic; 1239922

DR   Cosmic; 1305349

DR   Cosmic; 1312334

DR   Cosmic; 1434967

DR   Cosmic; 1436013

DR   Cosmic; 1477420

DR   Cosmic; 1802310

DR   Cosmic; 1870275

DR   Cosmic; 1945869

DR   Cosmic; 1995579

DR   Cosmic; 1998463

DR   Cosmic; 2042872

DR   Cosmic; 2125199

DR   Cosmic; 2433756

DR   Cosmic-CLP; 905943

DR   DSMZ; ACC-737

DR   ENCODE; ENCBS398KLJ

DR   ENCODE; ENCBS446PPO

DR   ENCODE; ENCBS460OUE

DR   ENCODE; ENCBS514AAA

DR   ENCODE; ENCBS515AAA

DR   ENCODE; ENCBS641PGO

DR   ENCODE; ENCBS686KKP

DR   ENCODE; ENCBS798ZFS

DR   ENCODE; ENCBS814QPR

DR   GDSC; 905943

DR   GEO; GSM50216

DR   GEO; GSM50279

DR   GEO; GSM206493

DR   GEO; GSM253335

DR   GEO; GSM385522

DR   GEO; GSM385533

DR   GEO; GSM434334

DR   GEO; GSM513936

DR   GEO; GSM514322

DR   GEO; GSM750809

DR   GEO; GSM784193

DR   GEO; GSM794288

DR   GEO; GSM799343

DR   GEO; GSM799406

DR   GEO; GSM827469

DR   GEO; GSM844652

DR   GEO; GSM844651

DR   GEO; GSM847076

DR   GEO; GSM887430

DR   GEO; GSM888510

DR   GEO; GSM1153414

DR   GEO; GSM1181352

DR   GEO; GSM1181361

DR   GEO; GSM1374746

DR   GEO; GSM1374747

DR   GEO; GSM1374748

DR   GEO; GSM1557134

DR   IGRhCellID; NCI-H460%20GEO

DR   IZSLER; BS TCL 197

DR   KCB; KCB 2010102YJ

DR   KCLB; 30177

DR   SKY/M-FISH/CGH; 2798

RX   PubMed=1563005;

RX   PubMed=2041050;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=15746151;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=19941903;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23381221;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24135919;

RX   PubMed=25120651;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=12

WW   http://www.addexbio.com/productdetail?pid=39

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-613.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 17.8 hours (DTP); ~23 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; KCLB; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9

ST   D18S51: 13,15

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 17,25

ST   D3S1358: 15,18

ST   D5S818: 9,10

ST   D7S820: 9,12

ST   D8S1179: 12

ST   FGA: 21,23

ST   Penta D: 11,13

ST   Penta E: 5

ST   TH01: 9.3

ST   TPOX: 8 (ATCC; Cosmic-CLP; DSMZ; PubMed=19372543; PubMed=25877200)

ST   TPOX: 9.3 (KCLB)

ST   vWA: 17

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-Luc

AC   CVCL_J264

DR   JCRB; JCRB1407

DR   JCRB; NIHS0658

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0658; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 13

ST   D16S539: 9

ST   D5S818: 9,10

ST   D7S820: 9,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-luc2

AC   CVCL_5J23

CC   Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).

CC   Discontinued: PerkinElmer; Catalog number 124316.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460-Red-Fluc

AC   CVCL_5J07

SY   NCI-H460 Red-Fluc

WW   http://www.perkinelmer.com/Catalog/Product/ID/BW124316

CC   Transfected with: UniProtKB; Q1AG35; Italian firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H460M

AC   CVCL_3969

SY   H460M; H-460M; H460-M

DR   BTO; BTO:0002836

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0459 ! NCI-H460

SX   Male

CA   Cancer cell line

//

ID   NCI-H462

AC   CVCL_A567

SY   H462; H-462

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A568 ! NCI-H463

SX   Male

CA   Cancer cell line

//

ID   NCI-H463

AC   CVCL_A568

SY   H463; H-463

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A567 ! NCI-H462

SX   Male

CA   Cancer cell line

//

ID   NCI-H478

AC   CVCL_A569

SY   H478; H-478

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H498

AC   CVCL_1563

SY   H498; H-498

DR   CLO; CLO_0008090

DR   ATCC; CCL-254

DR   BioSample; SAMN03471385

DR   GEO; GSM513915

DR   GEO; GSM514302

DR   GEO; GSM1448214

DR   KCLB; 10254

RX   PubMed=3479249;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=25926053;

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Peritoneum.

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 9,11

ST   D16S539: 9,11

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 8,11

ST   FGA: 22,24

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H508

AC   CVCL_1564

SY   NCI H508; NCIH508; H508; H-508

DR   CLO; CLO_0008091

DR   EFO; EFO_0002294

DR   ATCC; CCL-253

DR   BioSample; SAMN03471384

DR   CCLE; NCIH508_LARGE_INTESTINE

DR   Cosmic; 685870

DR   Cosmic; 908442

DR   Cosmic; 1479606

DR   Cosmic; 1565529

DR   Cosmic; 1708418

DR   Cosmic-CLP; 908442

DR   GDSC; 908442

DR   GEO; GSM513916

DR   GEO; GSM514303

DR   GEO; GSM741253

DR   GEO; GSM887431

DR   GEO; GSM888511

DR   GEO; GSM1448142

DR   GEO; GSM1670245

DR   IZSLER; BS TCL 214

DR   KCLB; 10253

DR   SKY/M-FISH/CGH; 5012

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 32 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Abdominal wall.

ST   Source(s): ATCC; Cosmic-CLP; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 12

ST   D3S1358: 14,17

ST   D5S818: 12

ST   D7S820: 8,12

ST   FGA: 24,25

ST   TH01: 9,9.3

ST   TPOX: 8,11

ST   vWA: 15,16

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H510A

AC   CVCL_1565

AS   CVCL_3973

SY   H510A; H-510A; NCI-H510; NCIH510; H510; H-510

DR   BTO; BTO:0003023

DR   CLO; CLO_0008092

DR   EFO; EFO_0006693

DR   ATCC; HTB-184

DR   BioSample; SAMN03473048

DR   CCLE; NCIH510_LUNG

DR   ChEMBL-Cells; CHEMBL3308322

DR   ChEMBL-Targets; CHEMBL2366332

DR   Cosmic; 753605

DR   Cosmic; 755466

DR   Cosmic; 897519

DR   Cosmic; 903575

DR   Cosmic; 1006527

DR   Cosmic; 1021865

DR   Cosmic; 1219103

DR   Cosmic; 1995580

DR   Cosmic; 2125210

DR   Cosmic-CLP; 753605

DR   DSMZ; ACC-568

DR   ECACC; 96020944

DR   GDSC; 753605

DR   GEO; GSM169437

DR   GEO; GSM784199

DR   GEO; GSM794289

DR   GEO; GSM887432

DR   GEO; GSM888512

DR   GEO; GSM1670246

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~1 week (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Adrenal gland.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 13

ST   D18S51: 15,17

ST   D21S11: 30

ST   D3S1358: 16,18

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   D8S1179: 15

ST   FGA: 22

ST   Penta D: 9,11

ST   Penta E: 12,16

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 15

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H513

AC   CVCL_A570

SY   H513; H-513; HUT513

DR   ATCC; CRL-5830

DR   BioSample; SAMN03151854

DR   Cosmic; 877271

DR   Cosmic; 877408

DR   Cosmic; 980997

DR   Cosmic; 1032388

DR   Cosmic; 1152503

DR   Cosmic; 1995420

DR   Cosmic-CLP; 1240141

DR   GDSC; 1240141

DR   GEO; GSM1669835

DR   KCLB; 90513

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=23830731;

RX   PubMed=27397505;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-H125 derivative.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: ATCC; CRL-5830; true.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 7

ST   D13S317: 11

ST   D16S539: 5,12

ST   D5S818: 10

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3968 ! NCI-H125

SX   Male

CA   Cancer cell line

//

ID   NCI-H520

AC   CVCL_1566

SY   H520; H-520; NCI-HUT-520; NCIH520

DR   BTO; BTO:0003014

DR   CLO; CLO_0008093

DR   EFO; EFO_0003124

DR   ATCC; HTB-182

DR   BCRC; 60124

DR   BioSample; SAMN03471318

DR   BioSample; SAMN03472735

DR   CCLE; NCIH520_LUNG

DR   CCRID; 3111C0001CCC000197

DR   ChEMBL-Cells; CHEMBL3307864

DR   ChEMBL-Targets; CHEMBL614099

DR   Cosmic; 687826

DR   Cosmic; 801591

DR   Cosmic; 876172

DR   Cosmic; 908443

DR   Cosmic; 917988

DR   Cosmic; 929974

DR   Cosmic; 932932

DR   Cosmic; 933580

DR   Cosmic; 945226

DR   Cosmic; 1028955

DR   Cosmic; 1146918

DR   Cosmic; 1219078

DR   Cosmic; 1239911

DR   Cosmic; 1741782

DR   Cosmic; 1802297

DR   Cosmic; 1995581

DR   Cosmic; 2060526

DR   Cosmic; 2125253

DR   Cosmic-CLP; 908443

DR   GDSC; 908443

DR   GEO; GSM63353

DR   GEO; GSM206494

DR   GEO; GSM276781

DR   GEO; GSM276782

DR   GEO; GSM434281

DR   GEO; GSM784258

DR   GEO; GSM794290

DR   GEO; GSM844653

DR   GEO; GSM844654

DR   GEO; GSM887433

DR   GEO; GSM888513

DR   GEO; GSM1374750

DR   GEO; GSM1670247

DR   IGRhCellID; NCIH520

DR   KCB; KCB 2013023YJ

RX   PubMed=8806092;

RX   PubMed=9649128;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,11

ST   D16S539: 8,13

ST   D18S51: 17

ST   D21S11: 30

ST   D3S1358: 16

ST   D5S818: 12,13 (ATCC; Cosmic-CLP)

ST   D5S818: 12 (PubMed=25877200)

ST   D7S820: 8,12

ST   D8S1179: 14,16,17

ST   FGA: 22

ST   Penta D: 13

ST   Penta E: 5,14

ST   TH01: 10

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H522

AC   CVCL_1567

SY   NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522

DR   BTO; BTO:0003536

DR   CLO; CLO_0008094

DR   EFO; EFO_0002295

DR   ATCC; CRL-5810

DR   BioSample; SAMN03471314

DR   CCLE; NCIH522_LUNG

DR   ChEMBL-Cells; CHEMBL3308392

DR   ChEMBL-Targets; CHEMBL614387

DR   Cosmic; 875853

DR   Cosmic; 877409

DR   Cosmic; 897509

DR   Cosmic; 903576

DR   Cosmic; 905944

DR   Cosmic; 974294

DR   Cosmic; 980965

DR   Cosmic; 1004696

DR   Cosmic; 1032437

DR   Cosmic; 1044246

DR   Cosmic; 1092622

DR   Cosmic; 1146919

DR   Cosmic; 1154592

DR   Cosmic; 1175866

DR   Cosmic; 1188591

DR   Cosmic; 1219062

DR   Cosmic; 1239883

DR   Cosmic; 1305350

DR   Cosmic; 1312335

DR   Cosmic; 1436012

DR   Cosmic; 1802320

DR   Cosmic; 1870276

DR   Cosmic; 1891886

DR   Cosmic; 1995582

DR   Cosmic; 1998464

DR   Cosmic; 2125185

DR   Cosmic-CLP; 905944

DR   GDSC; 905944

DR   GEO; GSM50217

DR   GEO; GSM50280

DR   GEO; GSM206495

DR   GEO; GSM353230

DR   GEO; GSM434309

DR   GEO; GSM513965

DR   GEO; GSM514350

DR   GEO; GSM750798

DR   GEO; GSM784233

DR   GEO; GSM794291

DR   GEO; GSM799344

DR   GEO; GSM799407

DR   GEO; GSM827479

DR   GEO; GSM847077

DR   GEO; GSM887434

DR   GEO; GSM888514

DR   GEO; GSM1153415

DR   GEO; GSM1181345

DR   GEO; GSM1181346

DR   GEO; GSM1374751

DR   GEO; GSM1374752

DR   GEO; GSM1374753

DR   GEO; GSM1670248

DR   IGRhCellID; NCIH522

DR   KCLB; 25810

DR   KCLB; 90522

DR   SKY/M-FISH/CGH; 2803

RX   PubMed=1563005;

RX   PubMed=2041050;

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19472407;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27807467;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=7

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   Doubling time: 38.2 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 25810; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12 (Cosmic-CLP; PubMed=19372543)

ST   CSF1PO: 10 (ATCC; PubMed=25877200)

ST   D13S317: 10

ST   D16S539: 12

ST   D18S51: 14,18

ST   D19S433: 16

ST   D21S11: 28,31.2

ST   D2S1338: 17,20

ST   D3S1358: 16

ST   D5S818: 10,11 (PubMed=19372543)

ST   D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D7S820: 9,10

ST   D8S1179: 12,13

ST   FGA: 24

ST   Penta D: 11

ST   Penta E: 11

ST   TH01: 7,9.3

ST   TPOX: 9,10

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H524

AC   CVCL_1568

SY   H524; H-524; NCIH524

DR   BTO; BTO:0004825

DR   CLO; CLO_0008095

DR   EFO; EFO_0002296

DR   ATCC; CRL-5831

DR   BioSample; SAMN03472976

DR   CCLE; NCIH524_LUNG

DR   CCRID; 3111C0001CCC000356

DR   ChEMBL-Cells; CHEMBL3308296

DR   ChEMBL-Targets; CHEMBL2366342

DR   Cosmic; 688024

DR   Cosmic; 844555

DR   Cosmic; 850442

DR   Cosmic; 877208

DR   Cosmic; 877358

DR   Cosmic; 908483

DR   Cosmic; 980933

DR   Cosmic; 1032399

DR   Cosmic; 1152472

DR   Cosmic; 1759289

DR   Cosmic; 1891904

DR   Cosmic; 2125200

DR   Cosmic-CLP; 908483

DR   GDSC; 908483

DR   GEO; GSM169442

DR   GEO; GSM794292

DR   GEO; GSM845548

DR   GEO; GSM887435

DR   GEO; GSM888515

DR   GEO; GSM1670249

DR   IGRhCellID; NCIH524

DR   KCB; KCB 2010137YJ

DR   KCLB; 90524

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 100 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90524; probable.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 12,13

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 11,12

ST   D8S1179: 13,15

ST   FGA: 25

ST   Penta D: 12,13

ST   Penta E: 5,15

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 14,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H526

AC   CVCL_1569

SY   H526; H-526; NCIH526

DR   BTO; BTO:0005366

DR   CLO; CLO_0008096

DR   ATCC; CRL-5811

DR   BioSample; SAMN03473065

DR   CCLE; NCIH526_LUNG

DR   ChEMBL-Cells; CHEMBL3308881

DR   ChEMBL-Targets; CHEMBL2366102

DR   Cosmic; 688025

DR   Cosmic; 755467

DR   Cosmic; 801615

DR   Cosmic; 844556

DR   Cosmic; 844820

DR   Cosmic; 850439

DR   Cosmic; 876164

DR   Cosmic; 877209

DR   Cosmic; 877359

DR   Cosmic; 918012

DR   Cosmic; 929975

DR   Cosmic; 1021866

DR   Cosmic; 1152473

DR   Cosmic; 1219104

DR   Cosmic; 1239940

DR   Cosmic; 1891905

DR   Cosmic; 1995583

DR   Cosmic; 1998284

DR   Cosmic; 2125214

DR   Cosmic-CLP; 688025

DR   GDSC; 688025

DR   GEO; GSM169439

DR   GEO; GSM380478

DR   GEO; GSM380515

DR   GEO; GSM536330

DR   GEO; GSM784231

DR   GEO; GSM794293

DR   GEO; GSM845549

DR   GEO; GSM844655

DR   GEO; GSM887436

DR   GEO; GSM888516

DR   GEO; GSM1374754

DR   GEO; GSM1670250

DR   IGRhCellID; NCIH526

DR   KCLB; 90526

DR   TOKU-E; 2701

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=10037197;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Bone marrow.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 9

ST   D18S51: 12,15

ST   D21S11: 27,32.2

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 9,12

ST   D8S1179: 14

ST   FGA: 22

ST   Penta D: 13,14

ST   Penta E: 5,13

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H548

AC   CVCL_1570

SY   NCI H548; H548; H-548; NCIH548

DR   CLO; CLO_0008097

DR   ATCC; CCL-249

DR   BioSample; SAMN03471379

DR   GEO; GSM1374755

DR   KCLB; 10249

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=20606684;

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CCL-249; true.

ST   Source(s): ATCC; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9,11

ST   D16S539: 11,13

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   FGA: 21,22

ST   TH01: 7

ST   TPOX: 10,11

ST   vWA: 15,18,19 (ATCC)

ST   vWA: 15,18 (KCLB)

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H568

AC   CVCL_A571

SY   H568; H-568

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H571

AC   CVCL_A572

SY   H571; H-571

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H578

AC   CVCL_A573

SY   H578; H-578

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H580

AC   CVCL_A574

SY   H580; H-580

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H596

AC   CVCL_1571

SY   H596; H-596; NCI-HUT-596; NCIH596

DR   BTO; BTO:0002209

DR   CLO; CLO_0008098

DR   EFO; EFO_0006694

DR   ATCC; HTB-178

DR   BioSample; SAMN03472805

DR   CCLE; NCIH596_LUNG

DR   CCRID; 3111C0001CCC000257

DR   ChEMBL-Cells; CHEMBL3307791

DR   ChEMBL-Targets; CHEMBL612256

DR   Cosmic; 687828

DR   Cosmic; 801586

DR   Cosmic; 844832

DR   Cosmic; 876226

DR   Cosmic; 897514

DR   Cosmic; 908459

DR   Cosmic; 918001

DR   Cosmic; 929973

DR   Cosmic; 934548

DR   Cosmic; 1067762

DR   Cosmic; 1146920

DR   Cosmic; 1188588

DR   Cosmic; 1219079

DR   Cosmic; 1239917

DR   Cosmic; 1694668

DR   Cosmic; 1802293

DR   Cosmic; 1995584

DR   Cosmic; 2125254

DR   Cosmic-CLP; 908459

DR   GDSC; 908459

DR   GEO; GSM206496

DR   GEO; GSM434310

DR   GEO; GSM784243

DR   GEO; GSM794294

DR   GEO; GSM844656

DR   GEO; GSM887437

DR   GEO; GSM888517

DR   GEO; GSM1374756

DR   GEO; GSM1374757

DR   GEO; GSM1670251

DR   IGRhCellID; NCIH596

DR   KCLB; 90596

DR   PRIDE; PXD002556

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=8806101;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=26361996;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,13

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 18

ST   D21S11: 29

ST   D3S1358: 14

ST   D5S818: 11,13

ST   D7S820: 11

ST   D8S1179: 13,14

ST   FGA: 23,25

ST   Penta D: 13

ST   Penta E: 12,15

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H60

AC   CVCL_A592

SY   H60; H-60

DR   ATCC; CRL-5821

DR   BioSample; SAMN03151862

DR   Cosmic; 1021848

DR   GEO; GSM1682797

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=6108156;

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

WW   http://www.atcc.org/support/faqs/d296a/NCIH60%20ATCC%20CRL5821-1064.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a NCI-N417 derivative.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5821; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 11,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1602 ! NCI-N417

SX   Female

CA   Cancer cell line

//

ID   NCI-H606

AC   CVCL_A575

SY   H606; H-606

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H615

AC   CVCL_A576

SY   H615; H-615

RX   PubMed=8806092;

RX   PubMed=8806103;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H618

AC   CVCL_A577

SY   H618; H-618

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H620

AC   CVCL_A578

SY   H620; H-620

DR   Cosmic; 1021868

DR   Cosmic; 1998276

DR   GEO; GSM536332

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Bone marrow.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H630

AC   CVCL_1572

SY   H630; H-630

DR   CLO; CLO_0008099

DR   EFO; EFO_0002297

DR   ATCC; CRL-5833

DR   BioSample; SAMN03151846

DR   BioSample; SAMN03481113

DR   ChEMBL-Cells; CHEMBL3307966

DR   ChEMBL-Targets; CHEMBL612540

DR   Cosmic; 687535

DR   Cosmic; 908482

DR   Cosmic; 1187327

DR   Cosmic-CLP; 908482

DR   GDSC; 908482

DR   GEO; GSM452725

DR   GEO; GSM452756

DR   GEO; GSM453572

DR   GEO; GSM454623

DR   GEO; GSM454643

DR   GEO; GSM454644

DR   GEO; GSM454645

DR   GEO; GSM1448143

DR   GEO; GSM1670252

DR   IGRhCellID; NCIH630

DR   IZSLER; BS TCL 191

DR   KCLB; 90630

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=27397505;

RX   PubMed=25926053;

WW   http://www.atcc.org/support/faqs/8fa42/NCIH630%20ATCC%20CRL5833-1065.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. The contaminant is not known. Seems to be a mixture of cell lines.

CC   Microsatellite instability: Instable (MSI-high) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ATCC; CRL-5833; true.

CC   Discontinued: KCLB; 90630; probable.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12,13,14 (ATCC)

ST   D13S317: 11,12,13 (Cosmic-CLP)

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 8,11,12

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,16,17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Undefined cell line type

//

ID   NCI-H64

AC   CVCL_1573

SY   H64; H-64

DR   ATCC; CRL-5976

DR   BioSample; SAMN03472629

DR   ChEMBL-Cells; CHEMBL3308273

DR   ChEMBL-Targets; CHEMBL2366319

DR   Cosmic; 688026

DR   Cosmic; 844544

DR   Cosmic; 953985

DR   Cosmic; 1995585

DR   Cosmic-CLP; 688026

DR   GDSC; 688026

DR   GEO; GSM1670253

RX   PubMed=2985257;

RX   PubMed=6108156;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10

ST   D16S539: 9,12

ST   D5S818: 11

ST   D7S820: 10,12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H640

AC   CVCL_A579

SY   H640; H-640

RX   PubMed=8806092;

RX   PubMed=11030152;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   NCI-H647

AC   CVCL_1574

SY   H647; H-647; H647ell; NCIH647

DR   BTO; BTO:0005294

DR   CLO; CLO_0008100

DR   ATCC; CRL-5834

DR   BioSample; SAMN03471319

DR   CCLE; NCIH647_LUNG

DR   ChEMBL-Cells; CHEMBL3308691

DR   ChEMBL-Targets; CHEMBL614999

DR   Cosmic; 722060

DR   Cosmic; 903577

DR   Cosmic; 931370

DR   Cosmic; 980966

DR   Cosmic; 1032438

DR   Cosmic; 1146921

DR   Cosmic; 1891887

DR   Cosmic-CLP; 1240191

DR   GDSC; 1240191

DR   GEO; GSM206497

DR   GEO; GSM434311

DR   GEO; GSM513970

DR   GEO; GSM514351

DR   GEO; GSM784213

DR   GEO; GSM794295

DR   GEO; GSM827587

DR   GEO; GSM844657

DR   GEO; GSM844658

DR   GEO; GSM887438

DR   GEO; GSM888518

DR   GEO; GSM1374758

DR   GEO; GSM1670254

DR   IGRhCellID; H647GEO

DR   KCLB; 90647

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: KCLB; 90647; probable.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,11

ST   D16S539: 9

ST   D18S51: 12,15

ST   D21S11: 28,32.2

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 11,13

ST   FGA: 22,24

ST   Penta D: 12,13

ST   Penta E: 7

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H650

AC   CVCL_1575

SY   H650; H-650

DR   BTO; BTO:0004079

DR   CLO; CLO_0008101

DR   EFO; EFO_0002298

DR   ATCC; CRL-5835

DR   BioSample; SAMN03471315

DR   CCLE; NCIH650_LUNG

DR   ChEMBL-Cells; CHEMBL3308461

DR   ChEMBL-Targets; CHEMBL1075543

DR   Cosmic; 722066

DR   Cosmic; 1609512

DR   Cosmic; 1870277

DR   Cosmic; 1995586

DR   Cosmic-CLP; 722066

DR   GDSC; 722066

DR   GEO; GSM206498

DR   GEO; GSM794296

DR   GEO; GSM827481

DR   GEO; GSM887439

DR   GEO; GSM888519

DR   GEO; GSM1670255

DR   IGRhCellID; NCIH650

DR   KCLB; 90650

RX   PubMed=8806092;

RX   PubMed=11030152;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 8,11

ST   D18S51: 14,20

ST   D21S11: 31

ST   D3S1358: 17

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 12,14

ST   FGA: 20,22

ST   Penta D: 12

ST   Penta E: 12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H650-Luc

AC   CVCL_4Y16

DR   JCRB; NIHS0729

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1575 ! NCI-H650

SX   Male

CA   Cancer cell line

//

ID   NCI-H660

AC   CVCL_1576

SY   H660; H-660; NCIH660; NCI660

DR   BTO; BTO:0001970

DR   CLO; CLO_0008102

DR   ATCC; CRL-5813

DR   BioSample; SAMN03473052

DR   CCLE; NCIH660_PROSTATE

DR   Cosmic; 877360

DR   Cosmic; 1021869

DR   Cosmic; 1043331

DR   Cosmic; 1075272

DR   Cosmic; 1689713

DR   Cosmic-CLP; 1330975

DR   GEO; GSM482672

DR   GEO; GSM648822

DR   GEO; GSM887440

DR   GEO; GSM888520

DR   GEO; GSM1670256

DR   IGRhCellID; NCIH660

RX   PubMed=1563005;

RX   PubMed=2985257;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

RX   PubMed=14518029;

RX   PubMed=22460905;

RX   PubMed=23671654;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   http://capcelllines.ca/details.asp?id=157

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 100 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 11

ST   D18S51: 15,16

ST   D21S11: 28,31

ST   D3S1358: 14,18

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 9,10

ST   FGA: 23,24

ST   Penta D: 9,12

ST   Penta E: 12

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H661

AC   CVCL_1577

SY   H661; H-661; NCIH661

DR   BTO; BTO:0003013

DR   CLO; CLO_0008103

DR   EFO; EFO_0002299

DR   ATCC; HTB-183

DR   BCRC; 60125

DR   BioSample; SAMN03471326

DR   CCLE; NCIH661_LUNG

DR   CCRID; 3111C0001CCC000357

DR   CCRID; 3131C0001000700121

DR   ChEMBL-Cells; CHEMBL3308139

DR   ChEMBL-Targets; CHEMBL1075544

DR   Cosmic; 687829

DR   Cosmic; 877410

DR   Cosmic; 903578

DR   Cosmic; 909909

DR   Cosmic; 923400

DR   Cosmic; 930610

DR   Cosmic; 933579

DR   Cosmic; 961835

DR   Cosmic; 980967

DR   Cosmic; 1006540

DR   Cosmic; 1032439

DR   Cosmic; 1146922

DR   Cosmic; 1152504

DR   Cosmic; 1219063

DR   Cosmic; 1239923

DR   Cosmic; 1995587

DR   Cosmic; 2125186

DR   Cosmic-CLP; 687829

DR   GDSC; 687829

DR   GEO; GSM185870

DR   GEO; GSM206499

DR   GEO; GSM253359

DR   GEO; GSM434273

DR   GEO; GSM784198

DR   GEO; GSM794297

DR   GEO; GSM827517

DR   GEO; GSM887441

DR   GEO; GSM888521

DR   GEO; GSM1670257

DR   IGRhCellID; NCIH661

DR   IZSLER; BS TCL 218

DR   KCB; KCB 200823YJ

RX   PubMed=8806092;

RX   PubMed=9649128;

RX   PubMed=11030152;

RX   PubMed=11369051;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: AKT genetic alteration cell panel (ATCC TCP-1029).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 61 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 12

ST   D18S51: 11

ST   D21S11: 31,33.2

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 8,10

ST   D8S1179: 10

ST   FGA: 20

ST   Penta D: 11,13

ST   Penta E: 12,13

ST   TH01: 8

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H676B

AC   CVCL_1578

SY   H676B; H-676B; NCI-H676; H676; H-676

DR   CLO; CLO_0008104

DR   ATCC; HTB-179

DR   BioSample; SAMN03472732

RX   PubMed=8626706;

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 9

ST   D13S317: 10

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H678

AC   CVCL_A580

SY   H678; H-678

DR   Cosmic; 1998277

DR   GEO; GSM536333

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H679

AC   CVCL_A581

SY   H679; H-679

DR   ATCC; CRL-5977

RX   PubMed=1563005;

RX   PubMed=8806092;

RX   PubMed=11030152;

CC   Discontinued: ATCC; CRL-5977; true.

DI   NCIt; C4038; Lung carcinoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H684

AC   CVCL_9980

SY   H684; H-684

DR   CCLE; NCIH684_LIVER

DR   GEO; GSM1448215

DR   KCLB; 90684

RX   PubMed=3479249;

RX   PubMed=8806092;

RX   PubMed=25926053;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): KCLB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D3S1358: 17,18

ST   D5S818: 11

ST   D7S820: 10,11

ST   FGA: 23

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H689

AC   CVCL_A582

SY   H689; H-689

DR   KCLB; 90689

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=11030152;

CC   Discontinued: KCLB; 90689; probable.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H69

AC   CVCL_1579

SY   NCI-H-69; NCI H69; H69; H-69; NCIH69; NCI-HUT-69; H69/P; NCI-H69C; H69C; H69c

DR   BTO; BTO:0003022

DR   CLO; CLO_0003609

DR   CLO; CLO_0008105

DR   EFO; EFO_0002300

DR   CLDB; cl1552

DR   ATCC; HTB-119

DR   BioSample; SAMN03473085

DR   CCLE; NCIH69_LUNG

DR   CCRID; 3111C0001CCC000358

DR   ChEMBL-Cells; CHEMBL3307712

DR   ChEMBL-Targets; CHEMBL614805

DR   CLS; 300185/p530_NCI-H69

DR   Cosmic; 688027

DR   Cosmic; 713879

DR   Cosmic; 755459

DR   Cosmic; 801610

DR   Cosmic; 808518

DR   Cosmic; 844545

DR   Cosmic; 844817

DR   Cosmic; 876167

DR   Cosmic; 877351

DR   Cosmic; 918010

DR   Cosmic; 929160

DR   Cosmic; 1006522

DR   Cosmic; 1021849

DR   Cosmic; 1152461

DR   Cosmic; 1175859

DR   Cosmic; 1212189

DR   Cosmic; 1219096

DR   Cosmic; 1239934

DR   Cosmic; 1434964

DR   Cosmic; 1571755

DR   Cosmic; 1609516

DR   Cosmic; 1995588

DR   Cosmic; 1998272

DR   Cosmic; 2125215

DR   Cosmic; 2239080

DR   Cosmic-CLP; 688027

DR   ECACC; 91091802

DR   GDSC; 688027

DR   GEO; GSM169443

DR   GEO; GSM380498

DR   GEO; GSM536334

DR   GEO; GSM784197

DR   GEO; GSM794269

DR   GEO; GSM827305

DR   GEO; GSM845550

DR   GEO; GSM844659

DR   GEO; GSM887442

DR   GEO; GSM888522

DR   GEO; GSM1670258

DR   IGRhCellID; NCIH69

DR   IZSLER; BS TCL 172

DR   KCLB; 30119

RX   PubMed=2574988;

RX   PubMed=2985257;

RX   PubMed=2985258;

RX   PubMed=3034934;

RX   PubMed=6108156;

RX   PubMed=7736387;

RX   PubMed=8626706;

RX   PubMed=8712684;

RX   PubMed=8806092;

RX   PubMed=8806103;

RX   PubMed=9212023;

RX   PubMed=9559344;

RX   PubMed=9744504;

RX   PubMed=9815546;

RX   PubMed=10037197;

RX   PubMed=11005564;

RX   PubMed=11030152;

RX   PubMed=11414198;

RX   PubMed=12569360;

RX   PubMed=19472407;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X,Y (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)

ST   Amelogenin: X (CLS)

ST   CSF1PO: 10,12 (ATCC; CLS; ECACC; KCLB)

ST   CSF1PO: 10,13 (Cosmic-CLP; PubMed=25877200)

ST   D13S317: 12

ST   D16S539: 11

ST   D18S51: 12 (CLS)

ST   D18S51: 12,15 (PubMed=25877200)

ST   D21S11: 30,31.2

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 9

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,11

ST   Penta E: 12

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 17 (Cosmic-CLP; PubMed=25877200)

ST   vWA: 16,17 (ATCC; CLS; ECACC; KCLB)

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/CPR

AC   CVCL_2137

SY   H69/CPR

DR   ECACC; 96042328

RX   PubMed=1327513;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX10

AC   CVCL_2138

SY   H69/LX10

DR   ECACC; 96042331

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX20

AC   CVCL_2139

SY   H69/LX20

DR   CLO; CLO_0008106

DR   ECACC; 96042332

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69/LX4

AC   CVCL_2140

SY   NCI H69-LX4; H69/LX4

DR   ECACC; 96042329

RX   PubMed=3011054;

RX   PubMed=3034934;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11,13

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H69VCR/R

AC   CVCL_3058

DR   ECACC; 96042330

CC   Selected for resistance to: ChEBI; CHEBI:28445; Vincristine (VCR).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 8,9

ST   TPOX: 10

ST   vWA: 16,17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1579 ! NCI-H69

SX   Male

CA   Cancer cell line

//

ID   NCI-H711

AC   CVCL_1580

SY   H711; H-711

DR   CLO; CLO_0008107

DR   ATCC; CRL-5836

DR   BioSample; SAMN03471749

DR   Cosmic; 844557

DR   Cosmic; 877211

DR   Cosmic; 877361

DR   Cosmic; 910709

DR   Cosmic; 1032400

DR   Cosmic; 1891906

DR   Cosmic; 2125255

DR   GEO; GSM169446

DR   GEO; GSM827535

RX   PubMed=8806092;

RX   PubMed=8806103;

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 9,13

ST   TH01: 9,9.3

ST   TPOX: 11

ST   vWA: 17

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   NCI-H716

AC   CVCL_1581

SY   NCI H716; H716; H-716; NCIH716

DR   BTO; BTO:0004747

DR   CLO; CLO_0008108

DR   EFO; EFO_0002301

DR   CLDB; cl3658

DR   ATCC; CCL-251

DR   BCRC; 60517

DR   BioSample; SAMN03473254

DR   CCLE; NCIH716_LARGE_INTESTINE

DR   CCRID; 3111C0001CCC000359

DR   CCRID; 3131C0001001200002

DR   ChEMBL-Cells; CHEMBL3308297

DR   ChEMBL-Targets; CHEMBL2366106

DR   Cosmic; 687536

DR   Cosmic; 908458

DR   Cosmic; 1995589

DR   Cosmic; 2302001

DR   Cosmic-CLP; 908458

DR   GDSC; 908458

DR   GEO; GSM513917

DR   GEO; GSM514304

DR   GEO; GSM887443

DR   GEO; GSM888523

DR   GEO; GSM1346850

DR   GEO; GSM1374759

DR   GEO; GSM1448144

DR   GEO; GSM1670259

DR   IGRhCellID; NCIH716

DR   KCLB; 10251

DR   SKY/M-FISH/CGH; 5013

RX   PubMed=1359704;

RX   PubMed=3479249;

RX   PubMed=8806089;

RX   PubMed=8806092;

RX   PubMed=8806095;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 50 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8,11

ST   D16S539: 11,12

ST   D18S51: 15,16

ST   D21S11: 32.2

ST   D3S1358: 16,18

ST   D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D5S818: 12 (KCLB)

ST   D7S820: 10,11

ST   D8S1179: 15

ST   FGA: 20,22

ST   Penta D: 9

ST   Penta E: 7,12

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C5543; Cecum adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 83及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。